 |
Psychiatry Archives 1. Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin
JW, Daumit G, Miller ER 3rd, Dalcin A, Jerome GJ, Geller S, Noronha
G, Pozefsky T, Charleston J, Reynolds JB, Durkin N, Rubin RR, Louis
TA, Brancati FL. Comparative effectiveness of weight-loss interventions
in clinical practice. N Engl J Med. 2011 Nov 24;365(21):1959-68. 2. Bittner AK, Ibrahim MA, Haythornthwaite JA,
Diener-West M, Dagnelie G. Vision test variability in retinitis pigmentosa
and psychosocial factors. Optom Vis Sci. 2011 Dec;88(12):1496-506. 3. Blom RM, Samuels JF, Grados MA, Chen Y, Bienvenu
OJ, Riddle MA, Liang KY, Brandt J, Nestadt G. Cognitive functioning
in compulsive hoarding. J Anxiety Disord. 2011 Dec;25(8):1139-44. 4. Cascella NG, Gerner GJ, Fieldstone SC, Sawa
A, Schretlen DJ. The insula-claustrum region and delusions in schizophrenia.
Schizophr Res. 2011 Dec; 133(1-3):77-81. 5. Dailey MJ, Moghadam AA, Moran TH. Jejunal linoleic
acid infusions require GLP-1 receptor signaling to inhibit food intake:
implications for the effectiveness of Roux-en-Y gastric bypass. Am J
Physiol Endocrinol Metab. 2011 Dec; 301(6):E1184-90. 6. Ginsburg GS, Kendall PC, Sakolsky D, Compton
SN, Piacentini J, Albano AM, Walkup JT, Sherrill J, Coffey KA, Rynn
MA, Keeton CP, McCracken JT, Bergman L, Iyengar S, Birmaher B, March
J. Remission after acute treatment in children and adolescents with
anxiety disorders: Findings from the CAMS. J Consult Clin Psychol. 2011
Dec; 79(6):806-13. 7. Griffiths RR, Johnson MW, Richards WA, Richards
BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences:
immediate and persisting dose-related effects. Psychopharmacology (Berl).
2011 Dec; 218(4):649-65. 8. Kidorf M, King VL, Peirce J, Kolodner K, Brooner
RK. A treatment reengagement intervention for syringe exchangers. J
Subst Abuse Treat. 2011 Dec;41(4):415-21. 9. Kondo M, Sawa A. Anti-/Propsychotic Drug Signaling
via Heteromeric GPCRs-A Balancing Act? Cell. 2011 Nov 23;147(5):964-5.
10. Kurtz PF, Boelter EW, Jarmolowicz DP, Chin
MD, Hagopian LP. An analysis of functional communication training as
an empirically supported treatment for problem behavior displayed by
individuals with intellectual disabilities. Res Dev Disabil. 2011 Nov;32(6):2935-42.
11. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung
SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R, Amzel LM, Berkowitz
DE, Snyder SH. Hydrogen sulfide as endothelium-derived hyperpolarizing
factor sulfhydrates potassium channels. Circ Res. 2011 Nov 11;109(11):1259-68.
12. Neufeld KJ, Joseph Bienvenu O, Rosenberg PB,
Mears SC, Lee HB, Kamdar BB, Sieber FE, Krumm SK, Walston JD, Hager
DN, Touradji P, Needham DM. The Johns Hopkins Delirium Consortium: a
model for collaborating across disciplines and departments for delirium
prevention and treatment. J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S244-8.
13. Smith GS, Kahn A, Sacher J, Rusjan P, van
Eimeren T, Flint A, Wilson AA. Serotonin Transporter Occupancy and the
Functional Neuroanatomic Effects of Citalopram in Geriatric Depression.
Am J Geriatr Psychiatry. 2011 Dec;19(12):1016-1025. 14. Snyder SH. What dopamine does in the brain.
Proc Natl Acad Sci U S A. 2011 Nov 22;108(47): 15. Weerts EM, Wand GS, Kuwabara H, Munro CA,
Dannals RF, Hilton J, Frost JJ, McCaul ME. Positron Emission Tomography
Imaging of Mu- and Delta-Opioid Receptor Binding in Alcohol-Dependent
and Healthy Control Subjects. Alcohol Clin Exp Res. 2011 Dec;35(12):2162-2173.
1. Duff K, Lyketsos
CG, Beglinger LJ, Chelune G, Moser DJ, Arndt S, Schultz SK, Paulsen
JS, Petersen RC, McCaffrey RJ. Practice effects predict cognitive outcome
in amnestic mild cognitive impairment. Am J Geriatr Psychiatry. 2011
Nov;19(11):932-9. 2. Hagopian LP, Rooker GW, Rolider NU. Identifying
empirically supported treatments for pica in individuals with intellectual
disabilities. Res Dev Disabil. 2011 Nov;32(6):2114-20. 3. Kano S, Nwulia E, Niwa M, Chen Y, Sawa A, Cascella
N. Altered MHC class I expression in dorsolateral prefrontal cortex
of nonsmoker patients with schizophrenia. Neurosci Res. 2011 Nov;71(3):289-93.
4. Lee RS, Tamashiro KL, Yang X, Purcell RH, Huo
Y, Rongione M, Potash JB, Wand GS. A measure of glucocorticoid load
provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl).
2011 Nov;218(1):303-12. 5. Moran TH, Dailey MJ. Intestinal feedback signaling
and satiety. Physiol Behav. 2011 Nov 30;105(1):77-81 6. Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu
X, McCaul ME. Naloxone-induced cortisol predicts mu opioid receptor
binding potential in specific brain regions of healthy subjects. Psychoneuroendocrinology.
2011 Nov;36(10):1453-9. 1. Chung DW, Rudnicki
DD, Yu L, Margolis RL. A natural antisense transcript at the Huntington's
disease repeat locus regulates HTT expression. Hum Mol Genet. 2011 Sep
1;20(17):3467-77. 2. Concheiro M, Jones HE, Johnson RE, Choo R,
Huestis MA. Preliminary buprenorphine sublingual tablet pharmacokinetic
data in plasma, oral fluid, and sweat during treatment of opioid-dependent
pregnant women. Ther Drug Monit. 2011 Oct;33(5):619-26. 3. Hennelly M, Yi J, Batkis M, Chisolm MS. Termination
of pregnancy in two patients during psychiatric hospitalization for
depressive symptoms and substance dependence. Psychosomatics. 2011 Sep-Oct;52(5):482-5.
4. Maroof DA, Gross AL, Brandt J. Modeling longitudinal
change in motor and cognitive processing speed in presymptomatic Huntington's
disease. J Clin Exp Neuropsychol. 2011 Oct;33(8):901-9. 5. McCann UD, Edwards RR, Smith MT, Kelley K,
Wilson M, Sgambati F, Ricaurte G. Altered pain responses in abstinent
(±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
users. Psychopharmacology (Berl). 2011 Oct;217(4):475-84. 6. Nucifora FC Jr, Hall RC, Everly GS Jr. Reexamining
the role of the traumatic stressor and the trajectory of posttraumatic
distress in the wake of disaster. Disaster Med Public Health Prep. 2011
Sep;5 Suppl 2:S172-5. 1. Blom RM, Samuels
JF, Riddle MA, Joseph Bienvenu O, Grados MA, Reti IM, EatonWW, Liang
KY, Nestadt G. Association between a serotonin transporter promoter
polymorphism (5HTTLPR) and personality disorder traits in a community
sample. J Psychiatr Res. 2011 Sep;45(9):1153-9. 2. Bruce ML, Bartels SJ, Lyness JM, Sirey JA,
Sheline YI, Smith G. Promoting the transition to independent scientist:
a national career development program. Acad Med. 2011 Sep;86(9):1179-1184.
3. Daumit GL, Dalcin AT, Jerome GJ, Young DR,
Charleston J, Crum RM, Anthony C, Hayes JH, McCarron PB, Khaykin E,
Appel LJ. A behavioral weight-loss intervention for persons with serious
mental illness in psychiatric rehabilitation centers. Int J Obes (Lond).
2011 Aug;35(8):1114-23. 4. de Medeiros K, Mosby A, Hanley KB, Pedraza
MS, Brandt J. A randomized clinical trial of a writing workshop intervention
to improve autobiographical memory and well-being in older adults. Int
J Geriatr Psychiatry. 2011 Aug;26(8):803-11. 5. Eze-Nliam CM, Quartana PJ, Quain AM, Smith
MT. Nocturnal heart rate variability is lower in temporomandibular disorder
patients than in healthy, pain-free individuals. J Orofac Pain. 2011
Summer;25(3):232-9. 6. Larson JJ, Yoon Y, Stewart M, dosReis S. Influence
of caregivers' experiences on service use among children with attention-deficit
hyperactivity disorder. Psychiatr Serv. 2011 Jul;62(7):734-9. 7. Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian
AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Neuropsychiatric
symptoms in Alzheimer's disease. Alzheimers Dement. 2011 Sep;7(5):532-9.
8. Mostofsky SH, Ewen JB. Altered connectivity
and action model formation in autism is autism. Neuroscientist. 2011
Aug;17(4):437-48. 9. Norton MC, Smith KR, Ostbye T, Tschanz JT,
Schwartz S, Corcoran C, Breitner JC, Steffens DC, Skoog I, Rabins PV,
Welsh-Bohmer KA; For the Cache County Investigators. Early parental
death and remarriage of widowed parents as risk factors for Alzheimer
Disease: The Cache County Study. Am J Geriatr Psychiatry.2011 Sep;19(9):814-824.
10. Purcell RH, Sun B, Pass LL, Power ML, Moran
TH, Tamashiro KL. Maternal stress and high-fat diet effect on maternal
behavior, milk composition, and pup ingestive behavior. Physiol Behav.
2011 Sep 1;104(3):474-9. 11. Rosenblatt A, Kumar BV, Margolis RL, Welsh
CS, Ross CA. Factors contributing to institutionalization in patients
with Huntington's disease. Mov Disord. 2011Aug 1;26(9):1711-6. 12. Salami O, Lyketsos C, Rao V. Treatment of
sleep disturbance in Alzheimer's dementia. Int J Geriatr Psychiatry.
2011 Aug;26(8):771-82. 13. Tamashiro KL, Sakai RR, Shively CA, Karatsoreos
IN, Reagan LP. Chronic stress, metabolism, and metabolic syndrome. Stress.
2011 Sep;14(5):468-74. 14. Tamashiro KL. Metabolic syndrome: links to
social stress and socioeconomic status. Ann N Y Acad Sci. 2011 Aug;1231(1):46-55.
15. Vandrey R, Smith MT, McCann UD, Budney AJ,
Curran EM. Sleep disturbance and the effects of extended-release zolpidem
during cannabis withdrawal. Drug Alcohol Depend. 2011 Aug 1;117(1):38-44.
16. Watkins CC, Pieper AA, Treisman GJ.
Safety considerations in drug treatment of depression in HIV-positive
patients: an updated review. Drug Saf. 2011 Aug 1;34(8):623-39. 1. Bellin MH, Dicianno
BE, Levey E, Dosa N, Roux G, Marben K, Zabel TA. Interrelationships
of sex, level of lesion, and transition outcomes among young adults
with myelomeningocele. Dev Med Child Neurol. 2011 Jul;53(7):647-652.
2. Campbell CM, Bounds
SC, Simango MB, Witmer KR, Campbell JN, Edwards RR, Haythornthwaite
JA, Smith MT. Self-reported sleep duration associated with distraction
analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin
nociceptive model. Eur J Pain. 2011 Jul;15(6):561-7. 3. Chao PT, Terrillion
CE, Moran TH, Bi S. High-fat diet offsets the long-lasting effects of
running-wheel access on food intake and body weight in OLETF rats. Am
J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1459-67. 4. Duke AN, Bigelow
GE, Lanier RK, Strain EC. Discriminative stimulus effects of tramadol
in humans. J Pharmacol Exp Ther. 2011 Jul;338(1):255-62. 5. Everly GS Jr, Davy
JA, Smith KJ, Lating JM, Nucifora FC Jr. A defining aspect of human
resilience in the workplace: a structural modeling approach. Disaster
Med Public Health Prep. 2011 Jun;5(2):98-105. 6. Goodin BR, Fillingim
RB, Machala S, McGuire L, Buenaver LF, Campbell CM, Smith MT. Subjective
sleep quality and ethnicity are interactively related to standard and
situation-specific measures of pain catastrophizing. Pain Med. 2011
Jun;12(6):913-22. 7. Horwitz SM, Heinberg
LJ, Storfer-Isser A, Barnes DH, Smith M, Kapur R, Findling R, Currier
G, Wilcox HC, Wilkens K. Teaching Physicians to Assess Suicidal Youth
Presenting to the Emergency Department. Pediatr Emerg Care. 2011Jul;27(7):601-605.
8. Howell PC, Larson
J, Coffey DB. Treatment of bipolar disorder in an adolescent with autistic
disorder: a diagnostic and treatment dilemma. J Child Adolesc Psychopharmacol.
2011 Jun;21(3):283-6. 9. Koga M, Serritella
AV, Messmer MM, Hayashi-Takagi A, Hester LD, Snyder SH, Sawa A, Sedlak
TW. Glutathione is a physiologic reservoir of neuronal glutamate. Biochem
Biophys Res Commun. 2011 Jun 17;409(4):596-602. 10. Liu CC, Wissow
L. How post-call resident doctors perform, feel and are perceived in
out-patient clinics. Med Educ. 2011 Jul;45(7):669-77. 11. Neufeld KJ, Schuckit
MA, Hernandez-Avila CA. Alcohol medical scholars program-a mentorship
program for improving medical education regarding substance use disorders.
Subst Abus. 2011 Jul;32(3):121-7. 12. Spinelli S, Vasa
RA, Joel S, Nelson TE, Pekar JJ, Mostofsky SH. Variability in post-error
behavioral adjustment is associated with functional abnormalities in
the temporal cortex in children with ADHD. J Child Psychol Psychiatry.
2011 Jul;52(7):808-16. 13. Stefanis NC, Mandelli
L, Hatzimanolis A, Zaninotto L, Smyrnis N, Avramopoulos D, Evdokimidis
I, Serretti A. Serotonin transporter gene variants and prediction of
stress-induced risk for psychological distress. Genes Brain Behav. 2011
Jul;10(5):536-41. 14. Wang Y, Steimle
PA, Ren Y, Ross CA, Robinson DN, Egelhoff TT, Sesaki H, Iijima M. Dictyostelium
huntingtin controls chemotaxis and cytokinesis through the regulation
of myosin II phosphorylation. Mol Biol Cell. 2011 Jul;22(13):2270-81.
15. Xiang Z, Valenza
M, Cui L, Leoni V, Jeong HK, Brilli E, Zhang J, Peng Q, Duan W, Reeves
SA, Cattaneo E, Krainc D. Peroxisome-Proliferator-Activated Receptor
Gamma Coactivator 1 {alpha} Contributes to Dysmyelination in Experimental
Models of Huntington's Disease. J Neurosci. 2011 Jun 29;31(26):9544-9553.
1. Amoyal NR, Mason
ST, Gould NF, Corry N, Mahfouz S, Barkey A, Fauerbach JA. Measuring
coping behavior in patients with major burn injuries: a psychometric
evaluation of the BCOPE. J Burn Care Res. 2011 May-Jun;32(3):392-8.
2. Aylward E, Mills
J, Liu D, Nopoulos P, Ross CA, Pierson R, Paulsen JS. Association between
age and striatal volume stratified by CAG repeat length in prodromal
Huntington Disease. PLoS Curr. 2011 May 11;3:RRN1235. 3. Becker KD, Ginsburg GS. Maternal anxiety,
behaviors, and expectations during a behavioral task: relation to children's
self-evaluations. Child Psychiatry Hum Dev. 2011 Jun;42(3):320-33. 4. Cheng Y, Peng Q, Hou Z, Aggarwal M, Zhang
J, Mori S, Ross CA, Duan W. Structural MRI detects progressive regional
brain atrophy and neuroprotective effects in N171-82Q Huntington's disease
mouse model. Neuroimage. 2011 Jun 1;56(3):1027-34. 5. Edwards RR, Quartana PJ, Allen RP, Greenbaum
S, Earley CJ, Smith MT. Alterations in pain responses in treated and
untreated patients with restless legs syndrome: Associations with sleep
disruption. Sleep Med. 2011 Jun;12(6):603-9. 6. Everly JJ, Defulio A, Koffarnus MN, Leoutsakos
JM, Donlin WD, Aklin WM,Umbricht A, Fingerhood M, Bigelow GE, Silverman
K. Employment-based reinforcementof adherence to depot naltrexone in
unemployed opioid-dependent adults: arandomized controlled trial. Addiction.
2011 Jul;106(7):1309-18. 7. Festa CC, Ginsburg GS. Parental and peer
predictors of social anxiety in youth. Child Psychiatry Hum Dev. 2011
Jun;42(3):291-306. 8. Goes FS, Rongione M, Chen YC, Karchin
R, Elhaik E; the Bipolar Genome Study, Potash JB. Exonic DNA Sequencing
of ERBB4 in Bipolar Disorder. PLoS One. 2011;6(5):e20242. 9. Koliatsos VE, Cernak I, Xu L, Song Y,
Savonenko A, Crain BJ, Eberhart CG,Frangakis CE, Melnikova T, Kim H,
Lee D. A mouse model of blast injury to brain: initial pathological,
neuropathological, and behavioral characterization. J Neuropathol Exp
Neurol. 2011 May;70(5):399-416. 10. Nowrangi MA, Rao V, Lyketsos CG. Epidemiology,
assessment, and treatment of dementia. Psychiatr Clin North Am. 2011
Jun;34(2):275-94. 11. Rabins PV, Kass NE, Rutkow L, Vernick
JS, Hodge JG. Challenges for mental health services raised by disaster
preparedness: mapping the ethical and therapeutic terrain. Biosecur
Bioterror. 2011 Jun;9(2):175-179. 12. Samuels J, Wang Y, Riddle MA, Greenberg
BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Knowles JA,
Piacentini J, Cullen B, Bienvenu OJ 3rd, Rasmussen SA, Geller D, Pauls
DL, Liang KY, Shugart YY, Nestadt G. Comprehensive family-based association
study of the glutamate transporter gene SLC1A1 in obsessive-compulsive
disorder. Am J Med Genet B Neuropsychiatr Genet. 2011 Jun;156(4):472-7.
13. Sojkova J, Zhou Y, An Y, Kraut MA, Ferrucci
L, Wong DF, Resnick SM. Longitudinal patterns of {beta}-amyloid deposition
in nondemented older adults. Arch Neurol. 2011 May;68(5):644-9. 14. Tschanz JT, Corcoran CD, Schwartz S,
Treiber K, Green RC, Norton MC, Mielke MM, Piercy K, Steinberg M, Rabins
PV, Leoutsakos JM, Welsh-Bohmer KA, Breitner JC, Lyketsos CG. Progression
of cognitive, functional, and neuropsychiatric symptom domains in a
population cohort with Alzheimer dementia: The Cache County Dementia
Progression Study. Am J Geriatr Psychiatry. 2011 Jun;19(6):532-542. 15. Zoubovsky SP, Pogorelov VM, Taniguchi
Y, Kim SH, Yoon P, Nwulia E, Sawa A, Pletnikov MV, Kamiya A. Working
memory deficits in neuronal nitric oxide synthase knockout mice: Potential
impairments in prefrontal cortex mediated cognitive function. Biochem
Biophys Res Commun. 2011 May 20;408(4):707-12. 1. Allman MJ, Deleon IG, Wearden JH. Psychophysical
assessment of timing in individuals with autism. Am J Intellect Dev
Disabil. 2011 Mar;116(2):165-78. 2. Chao PT, Yang L, Aja S, Moran TH, Bi S. Knockdown
of NPY Expression in the Dorsomedial Hypothalamus Promotes Development
of Brown Adipocytes and Prevents Diet-Induced Obesity. Cell Metab. 2011
May 4;13(5):573-83. 3. Clark MR, Treisman GJ. Optimizing treatment
with opioids and beyond. Adv Psychosom Med. 2011;30: 92-112. 4. Clark MR, Treisman GJ. From stigmatized neglect
to active engagement. Adv Psychosom Med. 2011;30: 1-7. 5. Gray TR, Dams R, Choo RE, Jones HE, Huestis
MA. Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.
Forensic Sci Int. 2011 Mar 20;206(1-3):98-102. 6. Gould NF, McKibben JB, Hall R, Corry NH, Amoyal
NA, Mason ST, McCann UD, Fauerbach JA. Peritraumatic heart rate and
posttraumatic stress disorder in patients with severe burns. J Clin
Psychiatry. 2011 Apr;72(4):539-47. 7. Ishizuka K, Kamiya A, Oh EC, Kanki H, Seshadri
S, Robinson JF, Murdoch H, Dunlop AJ, Kubo K, Furukori K, Huang B, Zeledon
M, Hayashi-Takagi A, Okano H, Nakajima K, Houslay MD, Katsanis N, Sawa
A. DISC1-dependent switch from progenitor proliferation to migration
in the developing cortex. Nature. 2011 May 5;473(7345):92-6. 8. Johnson MW, Maclean KA, Reissig CJ, Prisinzano
TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin
A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
Drug Alcohol Depend. 2011 May 1;115(1-2):150-5. 9. Jones HE, O'Grady KE, Tuten M. Reinforcement-based
treatment improves the maternal treatment and neonatal outcomes of pregnant
patients enrolled in comprehensive care treatment. Am J Addict. 2011
May;20 (3):196-204. 10. Jones HE, Tuten M, O'Grady KE. Treating the
partners of opioid-dependent pregnant patients: feasibility and efficacy.
Am J Drug Alcohol Abuse. 2011 May;37(3):170-8. 11. Kidorf M, King VL, Pierce J, Kolodner K, Brooner
RK. Benefits of concurrent syringe exchange and substance abuse treatment
participation. J Subst Abuse Treat. 2011 Apr;40(3):265-71. 12. Moran TH, Ladenheim EE. Adiposity signaling
and meal size control. Physiol Behav. 2011 Apr 18;103(1):21-4. 13. Pontone GM, Williams JR, Anderson KE, Chase
G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis
RL, Rabins PV, Weiss HD, Marsh L. Anxiety and self-perceived health
status in Parkinson's disease. Parkinsonism Relat Disord. 2011 May;17(4):249-54.
14. Shahani N, Sawa A. Nitric oxide signaling
and nitrosative stress in neurons: role for s-nitrosylation. Antioxid
Redox Signal. 2011 Apr 15;14(8):1493-504. 15. Treisman GJ, Clark MR. A behaviorist perspective.
Adv Psychosom Med. 2011;30:8-21. 1. Belmonte Mahon P,
Pirooznia M, Goes FS, Seifuddin F, Steele J, Lee PH, Huang J, Hamshere
ML; The Bipolar Genome Study (BiGS) Consortium, The Wellcome Trust Case
Control Consortium Bipolar Disorder Group, Depaulo JR Jr, Kelsoe JR,
Rietschel M, Nöthen M, Cichon S, Gurling H, Purcell S, Smoller
JW, Craddock N, Schulze TG, McMahon FJ, Potash JB, Zandi PP. Genome-wide
association analysis of age at onset and psychotic symptoms in bipolar
disorder. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156(3):370-378 2. Carroll CP, Haythornthwaite
J. Maladaptive opioid use behaviors and psychiatric illness: what should
we do with what we know? Curr Pain Headache Rep. 2011 Apr;15(2):91-3.
3. Clark MR. Chronic
opioid therapy for chronic pain: an e-learning program to develop shared
decision-making and communication skills. Curr Pain Headache Rep. 2011
Apr;15(2):88-90. 4. Fallin MD, Lasseter
VK, Liu Y, Avramopoulos D, McGrath J, Wolyniec PS, Nestadt G, Liang
KY, Chen PL, Valle D, Pulver AE. Linkage and association on 8p21.2-p21.1
in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):188-97.
5. Goodwin AK, Kaminski
BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration
of gamma-hydroxybutyrate (GHB) in baboons. Drug Alcohol Depend. 2011
Apr 1;114(2-3):217-24. 6. Hutton HE, Wilson
LM, Apelberg BJ, Avila Tang E, Odelola O, Bass EB, Chander G. A systematic
review of randomized controlled trials: web-based interventions for
smoking cessation among adolescents, college students, and adults. Nicotine
Tob Res. 2011 Apr;13(4):227-38. 7. Jayaram G, Doyle D, Steinwachs D, Samuels J.
Identifying and reducing medication errors in psychiatry: creating a
culture of safety through the use of an adverse event reporting mechanism.
J Psychiatr Pract. 2011 Mar;17(2):81-8. 8. Johnston D, Samus QM, Morrison A, Leoutsakos
JS, Hicks K, Handel S, Rye R, Robbins B, Rabins PV, Lyketsos CG, Black
BS. Identification of community-residing individuals with dementia and
their unmet needs for care. Int J Geriatr Psychiatry. 2011 Mar;26(3):292-8.
9. Leoutsakos JM, Bandeen-Roche K, Garrett-Mayer
E, Zandi PP. Incorporating scientific knowledge into phenotype development:
Penalized latent class regression. Stat Med. 2011 Mar 30;30(7):784-98.
doi: 10.1002/sim.4137. 10. Mejias R, Adamczyk A, Anggono V, Niranjan
T, Thomas GM, Sharma K, Skinner C, Schwartz CE, Stevenson RE, Fallin
MD, Kaufmann W, Pletnikov M, Valle D, Huganir RL, Wang T. Gain-of-function
glutamate receptor interacting protein 1 variants alter GluA2 recycling
and surface distribution in patients with autism. Proc Natl Acad Sci
U S A. 2011 Mar 22;108(12):4920-5. 11. Mroczkowski MM, Goes FS, Riddle MA, Grados
MA, Joseph Bienvenu O 3rd, Greenberg BD, Fyer AJ, McCracken JT, Rauch
SL, Murphy DL, Knowles JA, Piacentini J, Cullen B, Rasmussen SA, Geller
DA, Pauls DL, Liang KY, Nestadt G, Samuels JF. Separation anxiety disorder
in OCD. Depress Anxiety. 2011 Mar;28(3):256-62. 12. Mroczkowski MM, Redgrave GW, Miller NR, McCoy
AN, Guarda AS. Reversible vision loss secondary to malnutrition in a
woman with severe anorexia nervosa, purging type, and alcohol abuse.
Int J Eat Disord. 2011 Apr;44(3):281-3. 13. Neufeld KJ, Hayat MJ, Coughlin JM, Huberman
AL, Leistikow NA, Krumm SK, Needham DM. Evaluation of Two Intensive
Care Delirium Screening Tools for Non-Critically Ill Hospitalized Patients.
Psychosomatics. 2011 March - April;52(2):133-140. 14. Rosenberg PB, Mielke MM, Appleby B, Oh E,
Leoutsakos JM, Lyketsos CG. Neuropsychiatric symptoms in MCI subtypes:
the importance of executive dysfunction. Int J Geriatr Psychiatry. 2011
Apr;26(4):364-72. 15. Tompkins DA, Campbell CM. Opioid-induced hyperalgesia:
clinically relevant or extraneous research phenomenon? Curr Pain Headache
Rep. 2011 Apr;15(2):129-36. 1. Aretouli E, Okonkwo OC, Samek J, Brandt J.
The fate of the 0.5s: predictors of 2-year outcome in mild cognitive
impairment. J Int Neuropsychol Soc. 2011 Mar;17(2):277-88. 2. Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim
B, Krasnova IN, Sawa A, Margolis RL, Cadet JL, Mori S, Vogel MW, Ross
CA, Pletnikov MV. Differential effects of prenatal and postnatal expressions
of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice:
evidence for neurodevelopmental origin of major psychiatric disorders.
Mol Psychiatry. 2011 Mar;16(3):293-306. 3. Johnston D, Samus QM, Morrison A, Leoutsakos
JS, Hicks K, Handel S, Rye R, Robbins B, Rabins PV, Lyketsos CG, Black
BS. Identification of community-residing individuals with dementia and
their unmet needs for care. Int J Geriatr Psychiatry. 2011 Mar;26(3):292-8.
4. Murinson BB, Nenortas E, Mayer RS, Mezei L,
Kozachik S, Nesbit S, Haythornthwaite JA, Campbell JN. A new program
in pain medicine for medical students: integrating core curriculum knowledge
with emotional and reflective development. Pain Med. 2011 Feb;12(2):186-95.
5. Strain EC, Harrison JA, Bigelow GE. Induction
of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone
soluble-films. Clin Pharmacol Ther. 2011 Mar;89(3):443-9. 6. Wachtel LE, Jaffe R, Kellner CH. Electroconvulsive
therapy for psychotropic-refractory bipolar affective disorder and severe
self-injury and aggression in an 11-year-old autistic boy. Eur Child
Adolesc Psychiatry. 2011 Mar;20(3):147-52. 1. Arria AM, Caldeira KM, Kasperski SJ, Vincent
KB, Griffiths RR, O'Grady KE.Energy drink consumption and increased
risk for alcohol dependence. Alcohol Clin Exp Res. 2011 Feb;35(2):365-75. 2. Bienvenu OJ, Neufeld KJ. Post-traumatic stress
disorder in medical settings: focus on the critically ill. Curr Psychiatry
Rep. 2011 Feb;13(1):3-9. 3. Lyketsos CG, Weiller E, Katona C, Gorwood P.
Are old-old patients with major depression more likely to relapse than
young-old patients during continuation treatment with escitalopram?
BMC Geriatr. 2011 Jan 14;11(1):2. 4. Maag D, Maxwell MJ, Hardesty DA, Boucher KL,
Choudhari N, Hanno AG, Ma JF, Snowman AS, Pietropaoli JW, Xu R, Storm
PB, Saiardi A, Snyder SH, Resnick AC. Inositol polyphosphate multikinase
is a physiologic PI3-kinase that activates Akt/PKB. Proc Natl Acad Sci
U S A. 2011 Jan 25;108(4):1391-6. 5. Smith GS, Workman CI, Kramer E, Hermann CR,
Ginsberg R, Ma Y, Dhawan V, Chaly T, Eidelberg D. The relationship between
the acute cerebral metabolic response to citalopram and chronic citalopram
treatment outcome. Am J Geriatr Psychiatry. 2011 Jan;19(1):53-63. 6. Tristan C, Shahani N, Sedlak TW, Sawa A. The
diverse functions of GAPDH: views from different subcellular compartments.
Cell Signal. 2011 Feb;23(2):317-23. 7. Wilcox HC. Method used in an unsuccessful suicide
attempt predicts likelihood of future completed suicide. Evid Based
Ment Health. 2011 Feb;14(1):16. 1. Abazyan B, Nomura J, Kannan G, Ishizuka K,
Tamashiro KL, Nucifora F, Pogorelov V, Ladenheim B, Yang C, Krasnova
IN, Cadet JL, Pardo C, Mori S, Kamiya A, Vogel MW, Sawa A, Ross CA,
Pletnikov MV. Prenatal interaction of mutant DISC1 and immune activation
produces adult psychopathology. Biol Psychiatry. 2010 Dec 15;68(12):1172-81.
2. Appleby BS, Lyketsos CG. Rapidly progressive
dementias and the treatment of human prion diseases. Expert Opin Pharmacother.
2011 Jan;12(1):1-12. 3. Bienvenu OJ, Davydow DS, Kendler KS. Psychiatric
'diseases' versus behavioral disorders and degree of genetic influence.
Psychol Med. 2011 Jan;41(1):33-40. 4. Cascella NG, Kryszak D, Bhatti B, Gregory P,
Kelly DL, Mc Evoy JP, Fasano A, Eaton WW. Prevalence of celiac disease
and gluten sensitivity in the United States clinical antipsychotic trials
of intervention effectiveness study population. Schizophr Bull. 2011
Jan;37(1):94-100. 5. Coughlin JW, Edwards RR, Redgrave GW, Guarda
AS. Pain severity in eating disorders predicts longer inpatient hospitalization.
Int J Eat Disord. 2010 Dec;43(8):737-42. 6. Fagan PJ, Schuster AB, Boyd C, Marsteller JA,
Griswold M, Murphy SM, Dunbar L, Forrest CB. Chronic care improvement
in primary care: evaluation of an integrated pay-for-performance and
practice-based care coordination program among elderly patients with
diabetes. Health Serv Res. 2010 Dec;45(6 Pt 1):1763-82. 7. Frosch E, McCulloch J, Yoon Y, Dosreis S. Pediatric
emergency consultations: prior mental health service use in suicide
attempters. J Behav Health Serv Res. 2011 Jan;38(1):68-79. 8. Jones HE, Kaltenbach K, Heil SH, Stine SM,
Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G. Neonatal
abstinence syndrome after methadone or buprenorphine exposure. N Engl
J Med. 2010 Dec 9;363(24):2320-31. 9. Landa RJ, Holman KC, O'Neill AH, Stuart EA.
Intervention targeting development of socially synchronous engagement
in toddlers with autism spectrum disorder: a randomized controlled trial.
J Child Psychol Psychiatry. 2011 Jan;52(1):13-21. 10. Liang NC, Bello NT, Moran TH. Experience with
activity based anorexia enhances conditioned taste aversion learning
in rats. Physiol Behav. 2011 Jan 10;102(1):51-7. 11. López-Arvizu C, Sparrow EP, Strube
MJ, Slavin C, Deoleo C, James J, Hoover-Fong J, McIntosh I, Tierney
E. Increased symptoms of attention deficit hyperactivity disorder and
major depressive disorder symptoms in nail-patella syndrome: Potential
association with LMX1B loss-of-function. Am J Med Genet B Neuropsychiatr
Genet. 2011 Jan;156(1):59-66. 12. Mielke MM, Bandaru VV, McArthur JC, Chu M,
Haughey NJ. Disturbance in cerebral spinal fluid sphingolipid content
is associated with memory impairment in subjects infected with the human
immunodeficiency virus. J Neurovirol. 2010 Dec;16(6):445-56. 13. Ross CA, Tabrizi SJ. Huntington's disease:
from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011
Jan;10(1):83-98. 14. Schretlen DJ, van der Hulst EJ, Pearlson GD,
Gordon B. A neuropsychological study of personality: trait openness
in relation to intelligence, fluency, and executive functioning. J Clin
Exp Neuropsychol. 2010 Dec;32(10):1068-73. 15. Turin E, Grados MA, Tierney E, Ferenc LM,
Zabel A, Comi AM. Behavioral and psychiatric features of Sturge-Weber
syndrome. J Nerv Ment Dis. 2010 Dec;198(12):905-13. 1. Avramopoulos D. Genetics of psychiatric disorders
methods: molecular approaches. Clin Lab Med. 2010 Dec;30(4):815-27.
2. Consoli A, Benmiloud M, Wachtel L, Dhossche
D, Cohen D, Bonnot O. Electroconvulsive therapy in adolescents with
the catatonia syndrome: efficacy and ethics. J ECT. 2010 Dec;26(4):259-65.
3. Coughlin JW, Edwards RR, Redgrave GW, Guarda
AS. Pain severity in eating disorders predicts longer inpatient hospitalization.
Int J Eat Disord. 2010 Dec;43(8):737-42. 4. Fagan PJ, Schuster AB, Boyd C, Marsteller JA,
Griswold M, Murphy SM, Dunbar L,Forrest CB. Chronic care improvement
in primary care: evaluation of an integrated pay-for-performance and
practice-based care coordination program among elderly patients with
diabetes. Health Serv Res. 2010 Dec;45(6 Pt 1):1763-82. 5. Johnson AW, Han S, Blouin AM, Saini J, Worley
PF, During MJ, Holland PC, Baraban JM, Reti IM. Localized disruption
of Narp in medial prefrontal cortex blocks reinforcer devaluation performance.
Learn Mem. 2010 Nov 22;17(12):620-6. 6. Johnston D, Smith M, Beard-Byrd K, Albert A,
Legault C, McCall WV, Singleton A, Brenes G, Hogan P, Reifler B. A new
home-based mental health program for older adults: description of the
first 100 cases. Am J Geriatr Psychiatry. 2010 Dec;18(12):1141-5. 7. Mielke MM, Lyketsos CG. Alterations of the
sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment
targets? Neuromolecular Med. 2010 Dec;12(4):331-40. 8. Mielke MM, Zandi PP, Shao H, Waern M, Ostling
S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson DR. The 32-year
relationship between cholesterol and dementia from midlife to late life.
Neurology. 2010 Nov 23;75(21):1888-95. 9. Schlund MW, Cataldo MF. Amygdala involvement
in human avoidance, escape and approach behavior. Neuroimage. 2010 Nov
1;53(2):769-76. 10. Wachtel LE, Crawford TO, Dhossche DM, Reti
IM. Electroconvulsive therapy for pediatric malignant catatonia with
cerebellar dysgenesis. Pediatr Neurol. 2010 Dec;43(6):427-30. 11. Wilcox HC, Arria AM, Caldeira KM, Vincent
KB, Pinchevsky GM, O'Grady KE. Prevalence and predictors of persistent
suicide ideation, plans, and attempts during college. J Affect Disord.
2010 Dec;127(1-3):287-94. 12. Zandi PP, Judy JT. The promise and reality
of pharmacogenetics in psychiatry. Clin Lab Med. 2010 Dec;30(4):931-74.
1. Bello NT, Hajnal A. Dopamine and binge eating
behaviors. Pharmacol Biochem Behav. 2010 Nov;97(1):25-33. 2. Boyle L, Kaufmann WE. The behavioral phenotype
of FMR1 mutations. Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):469-76.
3. Jones HE, O'Grady KE, Johnson RE, Velez M,
Jansson LM. Infant neurobehavior following prenatal exposure to methadone
or buprenorphine: results from the neonatal intensive care unit network
neurobehavioral scale. Subst Use Misuse.2010 Nov;45(13):2244-57. 4. Knoepp LR, Shippey SH, Chen CC, Cundiff GW,
Derogatis LR, Handa VL. Sexual complaints, pelvic floor symptoms, and
sexual distress in women over forty. J Sex Med. 2010 Nov;7(11):3675-82.
5. Kuramoto SJ, Stuart EA, Runeson B, Lichtenstein
P, Långström N, Wilcox HC. Maternal or paternal suicide and
offspring's psychiatric and suicide-attempt hospitalization risk. Pediatrics.
2010 Nov;126(5):e1026-32. 6. O'Brien JW, Dowell LR, Mostofsky SH, Denckla
MB, Mahone EM. Neuropsychological profile of executive function in girls
with attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol.
2010 Nov;25(7):656-70. 7. Reese JB, Somers TJ, Keefe FJ, Mosley-Williams
A, Lumley MA. Pain and functioning of rheumatoid arthritis patients
based on marital status: is a distressed marriage preferable to no marriage?
J Pain. 2010 Oct;11(10):958-64. 1. Burstein M, Ginsburg GS, Tein JY. Parental
anxiety and child symptomatology: an examination of additive and interactive
effects of parent psychopathology. J Abnorm Child Psychol. 2010 Oct;38(7):897-909.
2. Chisolm MS, Brigham EP, Lookatch SJ, Tuten
M, Strain EC, Jones HE. Cigarette smoking knowledge, attitudes, and
practices of patients and staff at a perinatal substance abuse treatment
center. J Subst Abuse Treat. 2010 Oct;39(3):298-305. 3. Duan W, Ross CA. Potential therapeutic targets
for neurodegenerative diseases: lessons learned from calorie restriction.
Curr Drug Targets. 2010 Oct;11(10):1281-92. 4. Eze-Nliam CM, Thombs BD, Lima BB, Smith CG,
Ziegelstein RC. The association of depression with adherence to antihypertensive
medications: a systematic review. J Hypertens. 2010 Sep;28(9):1785-95.
5. Hayashi-Takagi A, Sawa A. Disturbed synaptic
connectivity in schizophrenia: convergence of genetic risk factors during
neurodevelopment. Brain Res Bull. 2010 Sep 30;83(3-4):140-6. 6. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey
A, Willour VL, Huo Y, Rongione M, Wand GS, Potash JB. Chronic corticosterone
exposure increases expression and decreases deoxyribonucleic acid methylation
of Fkbp5 in mice. Endocrinology. 2010 Sep; 151(9):4332-43. 7. Mintzer MZ, Lanier RK, Lofwall MR, Bigelow
GE, Strain EC. Effects of repeated tramadol and morphine administration
on psychomotor and cognitive performance in opioid-dependent volunteers.
Drug Alcohol Depend. 2010 Oct 1;111(3):265-8. 8. Wong DF, Kuwabara H, Horti AG, Raymont V, Brasic
J, Guevara M, Ye W, Dannals RF, Ravert HT, Nandi A, Rahmim A, Ming JE,
Grachev I, Roy C, Cascella N. Quantification of cerebral cannabinoid
receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the
novel PET radioligand [11C]OMAR. Neuroimage. 2010 Oct 1;52(4):1505-13.
1. Bello NT, Kemm MH, Ofeldt EM, Moran TH. Dose
combinations of exendin-4 and salmon calcitonin produce additive and
synergistic reductions in food intake in nonhuman primates. Am J Physiol
Regul Integr Comp Physiol. 2010 Sep;299(3):R945-52. 2. Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN,
Wang NY, Funderburk FR, Allen RP, David PM, Cadet JL. Polysomnogram
changes in marijuana users who report sleep disturbances during prior
abstinence. Sleep Med. 2010 Oct;11(9):882-9. 3. Campbell CM, Quartana PJ, Buenaver LF, Haythornthwaite
JA, Edwards RR. Changes in situation-specific pain catastrophizing precede
changes in pain report during capsaicin pain: a cross-lagged panel analysis
among healthy, pain-free participants. J Pain. 2010 Sep;11(9):876-84.
4. Eze-Nliam CM, Thombs BD, Lima BB, Smith CG,
Ziegelstein RC. The association of depression with adherence to antihypertensive
medications: a systematic review. J Hypertens. 2010 Sep;28(9):1785-95.
5. Fishman MJ, Winstanley EL, Curran E, Garrett
S, Subramaniam G. Treatment of opioid dependence in adolescents and
young adults with extended release naltrexone: preliminary case-series
and feasibility. Addiction. 2010 Sep;105(9):1669-76. 6. Johnson MW, Strain EC, Griffiths RR. Effects
of oral caffeine pretreatment on response to intravenous nicotine and
cocaine. Exp Clin Psychopharmacol. 2010 Aug;18(4):305-15. 7. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey
A, Willour VL, Huo Y, Rongione M, Wand GS, Potash JB. Chronic corticosterone
exposure increases expression and decreases deoxyribonucleic acid methylation
of Fkbp5 in mice. Endocrinology. 2010 Sep;151(9):4332-43. 8. Locascio G, Mahone EM, Eason SH, Cutting LE.
Executive dysfunction among children with reading comprehension deficits.
J Learn Disabil. 2010 Sep-Oct;43(5):441-54. 9. Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech
S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert
M, Lyketsos CG. Plasma ceramides are altered in mild cognitive impairment
and predict cognitive decline and hippocampal volume loss. Alzheimers
Dement. 2010 Sep;6(5):378-85. 10. Ramsey CM, Leoutsakos JM, Mayer LS, Eaton
WW, Lee HB. History of manic and hypomanic episodes and risk of incident
cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic
Catchment Area Study. J Affect Disord. 2010 Sep;125(1-3):35-41. 11. Rosenblatt A, Gao J, Mackell J, Richardson
S. Efficacy and safety of donepezil in patients with Alzheimer's disease
in assisted living facilities. Am J Alzheimers Dis Other Demen. 2010
Sep;25(6):483-9. 1. Aretouli E, Brandt J. Episodic memory in dementia:
Characteristics of new learning that differentiate Alzheimer's, Huntington's,
and Parkinson's diseases. Arch Clin Neuropsychol. 2010 Aug;25(5):396-409.
2. Cascella NG, Fieldstone SC, Rao VA, Pearlson
GD, Sawa A, Schretlen DJ. Gray-matter abnormalities in deficit schizophrenia.
Schizophr Res. 2010 Jul;120(1-3):63-70. 3. Duke AN, Correia CJ, Walsh SL, Bigelow GE,
Strain EC. Acute effects of intramuscular and sublingual buprenorphine
and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology
(Berl). 2010 Aug;211(3):303-12. 4. Jiang M, Porat-Shliom Y, Pei Z, Cheng Y, Xiang
L, Sommers K, Li Q, GillardonF, Hengerer B, Berlinicke C, Smith WW,
Zack DJ, Poirier MA, Ross CA, Duan W. Baicalein reduces E46K alpha-synuclein
aggregation in vitro and protects cells against E46K alpha-synuclein
toxicity in cell models of familiar Parkinsonism. J Neurochem. 2010
Jul;114(2):419-29. 5. Lehmann SW. A longitudinal "teaching-to-teach"
curriculum for psychiatric residents. Acad Psychiatry. 2010 Jul-Aug;34(4):282-6.
6. Murinson BB, Klick B, Haythornthwaite JA, Shochet
R, Levine RB, Wright SM. Formative experiences of emerging physicians:
gauging the impact of events that occur during medical school. Acad
Med. 2010 Aug;85(8):1331-1337. 7. Young-Pearse TL, Suth S, Luth ES, Sawa A, Selkoe
DJ. Biochemical and functional interaction of disrupted-in-schizophrenia
1 and amyloid precursor protein regulates neuronal migration during
mammalian cortical development. J Neurosci. 2010 Aug 4;30(31):10431-40.
1. Mahon PB, Stütz
AM, Seifuddin F, Huo Y, Goes FS, Jancic D, Judy JT, Depaulo JR Jr, Gershon
ES, McMahon FJ, Zandi PP, Potash JB, Willour VL. Case-control association
study of TGOLN2 in attempted suicide. Am J Med Genet B Neuropsychiatr
Genet. 2010 Jul;153B(5):1016-23. 2. Subramaniam S, Mealer RG, Sixt KM, Barrow RK,
Usiello A, Snyder SH. Rhes, a physiologic regulator of sumoylation,
enhances cross-sumoylation between the basic sumoylation enzymes E1
and Ubc9. J Biol Chem. 2010 Jul 2;285(27):20428-32. 3. Tamashiro KL, Moran TH. Perinatal environment
and its influences on metabolic programming of offspring. Physiol Behav.
2010 Jul 14;100(5):560-6. 4. Tompkins DA, Lanier RK, Harrison JA, Strain
EC, Bigelow GE. Human abuse liability assessment of oxycodone combined
with ultra-low-dose naltrexone. Psychopharmacology (Berl). 2010 Jul;210(4):471-80. 5. Wachtel LE, Dhossche DM. Self-injury
in autism as an alternate sign of catatonia: implications for electroconvulsive
therapy. Med Hypotheses. 2010 Jul;75(1):111-4. 1. Burstein M, Ginsburg
GS. The effect of parental modeling of anxious behaviors and cognitions
in school-aged children: an experimental pilot study. Behav Res Ther.
2010 Jun;48(6):506-15. 2. D'Agati D, Bloch Y, Levkovitz Y, Reti I. rTMS
for adolescents: Safety and efficacy considerations. Psychiatry Res.
2010 May 30;177(3):280-285. 3. Leoutsakos JM, Zandi PP, Bandeen-Roche K, Lyketsos
CG. Searching for valid psychiatric phenotypes: discrete latent variable
models. Int J Methods Psychiatr Res. 2010 Jun;19(2):63-73. 4. Sieber FE, Gottshalk A, Zakriya KJ, Mears SC,
Lee H. General anesthesia occurs frequently in elderly patients during
propofol-based sedation and spinal anesthesia. J Clin Anesth. 2010 May;22(3):179-83. 5. Wachtel LE, Hermida A, Dhossche DM. Maintenance
electroconvulsive therapy in autistic catatonia: a case series review.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):581-7.
1. Campbell CM, Witmer
K, Simango M, Carteret A, Loggia ML, Campbell JN, Haythornthwaite JA,
Edwards RR. Catastrophizing delays the analgesic effect of distraction.
Pain. 2010 May;149(2):202-7. 2. Cone EJ, Zichterman
A, Heltsley R, Black DL, Cawthon B, Robert T, Moser F, Caplan YH. Urine
testing for norcodeine, norhydrocodone, and noroxycodone facilitates
interpretation and reduces false negatives. Forensic Sci Int. 2010 May
20;198(1-3):58-61. 3. Dailey MJ, Tamashiro KL, Terrillion CE,
Moran TH. Nutrient specific feeding and endocrine effects of jejunal
infusions. Obesity (Silver Spring). 2010 May;18(5):904-10. 4. Huete JM, Kurtz PF. Therapist effects
on functional analysis outcomes with young children. Res Dev Disabil.
2010 May-Jun;31(3):804-10. 5. Kidorf M, King VL, Peirce J, Burke C,
Kolodner K, Brooner RK. Psychiatric distress, risk behavior, and treatment
enrollment among syringe exchange participants. Addict Behav. 2010 May;35(5):499-503. 6. Quartana PJ, Wickwire EM, Klick B, Grace
E, Smith MT. Naturalistic changes in insomnia symptoms and pain in temporomandibular
joint disorder: a cross-lagged panel analysis. Pain. 2010 May;149(2):325-31.
7. Schretlen DJ, Vannorsdall TD, Winicki
JM, Mushtaq Y, Hikida T, Sawa A, Yolken RH, Dickerson FB, Cascella NG.
Neuroanatomic and cognitive abnormalities related to herpes simplex
virus type 1 in schizophrenia. Schizophr Res. 2010 May;118(1-3):224-31.
1. Bello NT, Coughlin JW, Redgrave GW, Moran TH,
Guarda AS. Oral sensory and cephalic hormonal responses to fat and non-fat
liquids in bulimia nervosa. Physiol Behav. 2010 Apr 19;99(5):611-7 2. Horn PJ, Reti I, Jayaram G. Transdermal selegiline
in patients receiving electroconvulsive therapy. Psychosomatics. 2010
Mar;51(2):176-8. 3. Huete JM, Kurtz PF. Therapist effects on functional
analysis outcomes with young children. Res Dev Disabil. 2010 May-Jun;31(3):804-10.
4. Jaaro-Peled H, Ayhan Y, Pletnikov MV, Sawa
A. Review of pathological hallmarks of schizophrenia: comparison of
genetic models with patients and nongenetic models. Schizophr Bull.
2010 Mar;36(2):301-13 5. Payne JL, Fields ES, Meuchel JM, Jaffe CJ,
Jha M. Post adoption depression. Arch Womens Ment Health. 2010 Apr;13(2):147-51.
6. Rosenberg PB, Mielke MM, Xue QL, Carlson MC.
Depressive symptoms predict incident cognitive impairment in cognitive
healthy older women. Am J Geriatr Psychiatry. 2010 Mar;18(3):204-11.
7. Seshadri S, Kamiya A, Yokota Y, Prikulis I,
Kano S, Hayashi-Takagi A, Stanco A, Eom TY, Rao S, Ishizuka K, Wong
P, Korth C, Anton ES, Sawa A. Disrupted-in-Schizophrenia-1 expression
is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin
cascade. Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5622-7. 8. Schroeder M, Moran TH, Weller A. Attenuation
of obesity by early-life food restriction in genetically hyperphagic
male OLETF rats: peripheral mechanisms.Horm Behav. 2010 Apr;57(4-5):455-62.
1. Aretouli E, Brandt
J. Everyday functioning in mild cognitive impairment and its relationship
with executive cognition. Int J Geriatr Psychiatry. 2010 Mar;25(3):224-33.
2. Avramopoulos D. Genetics of psychiatric disorders
methods: molecular approaches. Psychiatr Clin North Am. 2010 Mar;33(1):1-13.
3. Goes FS, Willour VL, Zandi PP, Belmonte PL,
MacKinnon DF, Mondimore FM, Schweizer B; National Institute of Mental
Health Genetics Initiative Bipolar Disorder Consortium, DePaulo JR Jr,
Gershon ES, McMahon FJ, Potash JB. Sex-specific association of the Reelin
gene with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2010
Mar 5;153B(2):549-53. 4. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri
S, Murdoch H, Dunlop AJ, Makino Y, Seshadri AJ, Ishizuka K, Srivastava
DP, Xie Z, Baraban JM, Houslay MD, Tomoda T, Brandon NJ, Kamiya A, Yan
Z, Penzes P, Sawa A. Disrupted-in-Schizophrenia 1 (DISC1) regulates
spines of the glutamate synapse via Rac1. Nat Neurosci. 2010 Mar;13(3):327-32.
5. Johnson MW, Bickel WK, Baker F, Moore BA, Badger
GJ, Budney AJ. Delay discounting in current and former marijuana-dependent
individuals. Exp Clin Psychopharmacol. 2010 Feb;18(1):99-107. 6. Kleykamp BA, Griffiths RR, Mintzer MZ. Dose
effects of triazolam and alcohol on cognitive performance in healthy
volunteers. Exp Clin Psychopharmacol. 2010 Feb;18(1):1-16. 7. Maynard CS, Amari A, Wieczorek B, Christensen
JR, Slifer KJ. Interdisciplinary behavioral rehabilitation of pediatric
pain-associated disability: retrospective review of an inpatient treatment
protocol. J Pediatr Psychol. 2010 Mar;35(2):128-37. 8. Mintzer MZ, Kleykamp BA, Griffiths RR.
Dose effects of triazolam and scopolamine on metamemory. Exp Clin Psychopharmacol.
2010 Feb;18(1):17-31. 9. Nestadt G, Grados M, Samuels JF. Genetics
of obsessive-compulsive disorder. Psychiatr Clin North Am. 2010 Mar;33(1):141-58Z 10. Neufeld K, Kidorf M, King V, Stoller
K, Clark M, Peirce J, Brooner RK. Using enhanced and integrated services
to improve response to standard methadone treatment: changing the clinical
infrastructure of treatment networks. J Subst Abuse Treat. 2010 Mar;38(2):170-7.
11. Niwa M, Kamiya A, Murai R, Kubo K, Gruber
AJ, Tomita K, Lu L, Tomisato S, Jaaro-Peled H, Seshadri S, Hiyama H,
Huang B, Kohda K, Noda Y, O'Donnell P, Nakajima K, Sawa A, Nabeshima
T. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic
maturation in the frontal cortex and leads to adult behavioral deficits.
Neuron. 2010 Feb 25;65(4):480-9. 12. Quartana PJ, Buenaver LF, Edwards RR,
Klick B, Haythornthwaite JA, Smith MT. Pain catastrophizing and salivary
cortisol responses to laboratory pain testing in temporomandibular disorder
and healthy participants. J Pain. 2010 Feb;11(2):186-94. 13. Stitzer ML, Polk T, Bowles S, Kosten
T. Drug users' adherence to a 6-month vaccination protocol: effects
of motivational incentives. Drug Alcohol Depend. 2010 Feb 1;107(1):76-9.
14. Wang Y, Adamczyk A, Shugart YY, Samuels
JF, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy
DL, Rasmussen SA, Cullen B, Pinto A, Fyer AJ, Piacentini J, Pauls DL,
Bienvenu OJ, Riddle M, Liang KY, Valle D, Wang T, Nestadt G. A screen
of SLC1A1 for OCD-related alleles. Am J Med Genet B Neuropsychiatr Genet.
2010 Mar 5;153B(2):675-9. 15. Zandi PP, Judy JT. The promise and reality
of pharmacogenetics in psychiatry. Psychiatr Clin North Am. 2010 Mar;33(1):181-224.
1. Black BS, Rabins
PV, Sugarman J, Karlawish JH. Seeking assent and respecting dissent
in dementia research. Am J Geriatr Psychiatry. 2010 Jan;18(1):77-85. 2. Ishizuka K, Tajinda
K, Colantuoni C, Morita M, Winicki J, Le C, Lin S, Schretlen D, Sawa
A, Cascella NG. Negative symptoms of schizophrenia correlate with impairment
on the University of Pennsylvania smell identification test. Neurosci
Res. 2010 Jan;66(1):106-10. 3. Nestadt G, Di C,
Samuels JF, Bienvenu OJ, Reti IM, Costa P, Eaton WW, Bandeen-Roche K.
The stability of DSM personality disorders over twelve to eighteen years.
J Psychiatr Res. 2010 Jan;44(1):1-7. 4. Parakh K, Bhat U,
Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Self-assessed physical
health predicts 10-year mortality after myocardial infarction. J Cardiopulm
Rehabil Prev. 2010 Jan-Feb;30(1):35-9. 5. Rosenberg PB, Drye LT, Martin BK, Frangakis
C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV,
Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group. Sertraline
for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry.
2010 Feb;18(2):136-45. 6. Sieber FE, Zakriya KJ, Gottschalk A,
Blute MR, Lee HB, Rosenberg PB, Mears SC. Sedation depth during spinal
anesthesia and the development of postoperative delirium in elderly
patients undergoing hip fracture repair. Mayo Clin Proc. 2010 Jan;85(1):18-26.
7. Stitzer ML, Polk T, Bowles S, Kosten
T. Drug users' adherence to a 6-month vaccination protocol: effects
of motivational incentives. Drug Alcohol Depend. 2010 Feb 1;107(1):76-9.
1. Ator NA, Atack JR, Hargreaves RJ, Burns HD,
Dawson GR. Reducing abuse liability of GABAA/benzodiazepine ligands
via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.
J Pharmacol Exp Ther. 2010 Jan;332(1):4-16. 2. Bruck M. Human figure drawings and children's
recall of touching. J Exp Psychol Appl. 2009 Dec; 15(4):361-74. 3. Carter LP, Griffiths RR. Principles of laboratory
assessment of drug abuse liability and implications for clinical development.
Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1:S14-25. 4. Carter LP, Stitzer ML, Henningfield JE, O'Connor
RJ, Cummings KM, Hatsukami DK. Abuse liability assessment of tobacco
products including potential reduced exposure products. Cancer Epidemiol
Biomarkers Prev. 2009 Dec;18(12):3241-62. 5. Corry NH, Klick B, Fauerbach JA. Posttraumatic
stress disorder and pain impact functioning and disability after major
burn injury. J Burn Care Res. 2010 Jan-Feb; 31(1):13-25. 6. Moran TH. Hypothalamic Nutrient Sensing and
Energy Balance. Forum Nutr. 2010;63:94-101. 7. Margolis RL, Ross CA.Neuronal signaling pathways:
genetic insights into the pathophysiology of major mental illness. Neuropsychopharmacology.
2010 Jan; 35(1):350-1. 8. Mason ST, Corry N, Gould NF, Amoyal N, Gabriel
V, Wiechman-Askay S, Holavanahalli R, Banks S, Arceneaux L, Fauerbach
JA. Growth curve trajectories of distress in burn patients. J Burn Care
Res. 2010 Jan-Feb;31(1):64-72. 9. Neubauer DN. Almorexant, a dual orexin receptor
antagonist for the treatment of insomnia. Curr Opin Investig Drugs.
2010 Jan;11(1):101-10. 10. Tompkins DA, Bigelow GE, Harrison JA, Johnson
RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical Opiate
Withdrawal Scale (COWS) and single-item indices against the Clinical
Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug
Alcohol Depend. 2009 Nov 1;105(1-2):154-9. 1. Appleby BS. Psychotropic
medications and the treatment of human prion diseases. CNS Neurol Disord
Drug Targets. 2009 Nov;8(5):353-62. 2. Ayhan Y, Sawa A, Ross CA, Pletnikov MV. Animal
models of gene-environment interactions in schizophrenia. Behav Brain
Res. 2009 Dec 7;204(2):274-81 3. Carlson MC, Erickson KI, Kramer AF, Voss MW,
Bolea N, Mielke M, McGill S, Rebok GW, Seeman T, Fried LP. Evidence
for neurocognitive plasticity in at-risk older adults: the experience
corps program. J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1275-82. 4. McCann UD, Sgambati FP, Schwartz AR, Ricaurte
GA. Sleep apnea in young abstinent recreational MDMA ("ecstasy")
consumers. Neurology. 2009 Dec 8;73(23):2011-7. 5. Mielke MM, Bandaru VV, Haughey NJ, Rabins PV,
Lyketsos CG, Carlson MC. Serum 6. Moran TH. Hypothalamic Nutrient Sensing and
Energy Balance. Forum Nutr. 2010,63:94-101. 7. Smith MT, Quartana PJ, Okonkwo RM, Nasir
A. Mechanisms by which sleep disturbance contributes to osteoarthritis
pain: a conceptual model. Curr Pain Headache Rep. 2009 Dec,13(6):447-54. 1. Chisolm MS, Tuten M, Brigham EC, Strain EC,
Jones HE. Relationship between cigarette use and mood/anxiety disorders
among pregnant methadone-maintained patients. Am J Addict. 2009 Sep-Oct;18(5):422-9.
3. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S,
Kamiya A, Brandon NJ, Sawa A. Neurodevelopmental mechanisms of schizophrenia:
understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4
and DISC1. Trends Neurosci. 2009 4. Mahon PB, Payne JL, MacKinnon DF, Mondimore
FM, Goes FS, Schweizer B, Jancic D; NIMH Genetics Initiative Bipolar
Disorder Consortium; BiGS Consortium, Coryell WH, Holmans PA, Shi J,
Knowles JA, Scheftner WA, Weissman MM, Levinson DF, DePaulo JR Jr, Zandi
PP, Potash JB. Genome-wide linkage and follow-up association study of
postpartum mood symptoms. Am J Psychiatry. 2009 Nov;166(11):1229-37. 5. McCann UD, Wilson MJ, Sgambati FP, Ricaurte
GA. Sleep deprivation differentially impairs cognitive performance in
abstinent methylenedioxymethamphetamine ("ecstasy") users.
J Neurosci. 2009 Nov 4;29(44):14050-6. 6. Testa SM, Winicki JM, Pearlson GD, Gordon B,
Schretlen DJ. Accounting for estimated IQ in neuropsychological test
performance with regression-based techniques. J Int Neuropsychol Soc.
2009 Nov;15(6):1012-22. 7. Tompkins DA, Bigelow GE, Harrison JA,
Johnson RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical
Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical
Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug
Alcohol Depend. 2009 Nov 1;105(1-2):154-9. 1. Brandt J, Aretouli E, Neijstrom E, Samek J,
Manning K, Albert MS, Bandeen-Roche K. Selectivity of executive function
deficits in mild cognitive impairment. Neuropsychology. 2009 Sep;23(5):607-18. 2. Carroll CP, Triplett PT, Mondimore FM. The
Intensive Treatment Unit: A brief inpatient detoxification facility
demonstrating good post detoxification treatment entry. J Subst Abuse
Treat. 2009 Sep; 37(2):111-9. 3. Grover D, Verma R, Goes FS, Mahon PL, Gershon
ES, McMahon FJ, Potash JB; NIMH Genetics Initiative Bipolar Disorder
Collaborative, Bipolar Disorder Phenome Group, Gershon ES, McMahon FJ,
Potash JB. Family-based association of YWHAH in psychotic bipolar disorder.
Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B (7):977-83. 4. Subramaniam GA, Fishman MJ, Woody G. Treatment
of opioid-dependent adolescents and young adults with buprenorphine.
Curr Psychiatry Rep. 2009 Oct;11(5):360-3. 1. Bello NT, Guarda
AS, Terrillion CE, Redgrave GW, Coughlin JW, Moran TH. Repeated binge
access to a palatable food alters feeding behavior, hormone profile,
and hindbrain c-Fos responses to a test meal in adult male rats. Am
J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R622-31. 2. DosReis S, Mychailyszyn MP, Evans-Lacko SE,
Beltran A, Riley AW, Myers MA. The meaning of attention-deficit/hyperactivity
disorder medication and parents' initiation and continuity of treatment
for their child. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):377-83.
3. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S,
Kamiya A, Brandon NJ, Sawa A. Neurodevelopmental mechanisms of schizophrenia:
understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4
and DISC1. Trends Neurosci. 2009 Sep;32(9):485-95. 4. Nestadt G, Di CZ, Riddle MA, Grados MA, Greenberg
BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen
B, Pinto A, Knowles JA, Piacentini J, Pauls DL, Bienvenu OJ, Wang Y,
Liang KY, Samuels JF, Roche KB. Obsessive-compulsive disorder: subclassification
based on co-morbidity. Psychol Med. 2009 Sep;39(9):1491-501. 5. Neubauer DN, Flaherty KN. Chronic insomnia.
Semin Neurol. 2009 Sep;29(4):340-53. 6. Rabins P, Appleby BS, Brandt J, DeLong MR,
Dunn LB, Gabriëls L, Greenberg BD, 7. Rosenberg PB, Hillis AE. Biomarkers for Alzheimer's
disease: ready for the next step. Brain. 2009 Aug;132(Pt 8):2002-4.
8. Rosenberg RE, Daniels AM, Law JK, Law PA, Kaufmann
WE. Trends in autism spectrum disorder diagnoses: 1994-2007. J Autism
Dev Disord. 2009 Aug;39(8):1099-111. 9. Samuels JF. Recent advances in the genetics
of obsessive-compulsive disorder. Curr Psychiatry Rep. 2009 Aug;11(4):277-82.
10. Tompkins DA, Bigelow GE, Harrison JA, Johnson
RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical Opiate
Withdrawal Scale (COWS) and single-item indices against the Clinical
Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug
Alcohol Depend. 2009 Nov 1;105(1-2):154-9. 1. Liang Y, Jiang H,
Ratovitski T, Jie C, Nakamura M, Hirschhorn RR, Wang X, Smith WW, Hai
T, Poirier MA, Ross CA. ATF3 plays a protective role against toxicity
by N-terminal fragment of mutant huntingtin in stable PC12 cell line.
Brain Res. 2009 Aug 25;1286:221-9. 2. Nestadt G, Di CZ, Riddle MA, Grados MA, Greenberg
BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen
B, Pinto A, Knowles JA, Piacentini J, Pauls DL, Bienvenu OJ, Wang Y,
Liang KY, Samuels JF, Roche KB. Obsessive-compulsive disorder: subclassification
based on co-morbidity. PsycholMed. 2009 Sep;39(9):1491-501. 3. Pontone GM, Williams JR, Anderson KE, Chase
G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis
RL, Rabins PV, Weiss HD, Marsh L. Prevalence of anxiety disorders and
anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009
Jul 15;24(9):1333-8. 4. Samuels JF. Recent advances in the genetics
of obsessive-compulsive disorder. 5. Schretlen DJ, Winicki JM, Meyer SM, Testa
SM, Pearlson GD, Gordon B. Development, psychometric properties, and
validity of the Hopkins Adult Reading Test (HART). Clin Neuropsychol.
2009 Aug;23(6):926-43. 1. Bienvenu OJ, Wang
Y, Shugart YY, Welch JM, Grados MA, Fyer AJ, Rauch SL, McCracken JT,
Rasmussen SA, Murphy DL, Cullen B, Valle D, Hoehn-Saric R, Greenberg
BD, Pinto A, Knowles JA, Piacentini J, Pauls DL, Liang KY, Willour VL,
Riddle M, Samuels JF, Feng G, Nestadt G. Sapap3 and pathological grooming
in humans: Results from the OCD collaborative genetics study. Am J Med
Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):710-20. 2. Bradshaw CP, Koth CW, Thornton LA, Leaf PJ.
Altering school climate through school-wide Positive Behavioral Interventions
and Supports: findings from a group-randomized effectiveness trial.
Prev Sci. 2009 Jun;10(2):100-15. 3. Brandt J, Manning KJ. Patterns of word-list
generation in mild cognitive impairment and Alzheimer's disease. Clin
Neuropsychol. 2009 Jul;23(5):870-9. 4. Goes FS, Willour VL, Zandi PP, Belmonte PL,
MacKinnon DF, Mondimore FM, Schweizer B, Gershon ES, McMahon FJ, Potash
JB; Bipolar Disorder Phenome Group; NIMH Genetics Initiative Bipolar
Disorder Consortium. Family-based association study of Neuregulin 1
with psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet.
2009 Jul 5;150B(5):693-702. 5. Goodwin AK, Brown PR, Jansen EE, Jakobs C,
Gibson KM, Weerts EM. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate
(GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD)
in baboons. Psychopharmacology (Berl). 2009 Jun;204(3):465-76. 6. Moran TH, Dailey MJ. Minireview: Gut peptides:
targets for antiobesity drug development? Endocrinology. 2009 Jun;150(6):2526-30.
7. Singer HS, Morris C, Gause C, Pollard M, Zimmerman
AW, Pletnikov M. Prenatal exposure to antibodies from mothers of children
with autism produces neurobehavioral alterations: A pregnant dam mouse
model. J Neuroimmunol. 2009 Jun 25;211(1-2):39-48. 8. Smith MT, Wickwire EM, Grace EG, Edwards RR,
Buenaver LF, Peterson S, Klick B, Haythornthwaite JA. Sleep disorders
and their association with laboratory pain sensitivity in temporomandibular
joint disorder. Sleep. 2009 Jun 1;32(6):779-90. 9. Steinberg M, Leoutsakos JM, Podewils LJ, Lyketsos
CG. Evaluation of a home-based exercise program in the treatment of
Alzheimer's disease: the Maximizing Independence in Dementia (MIND)
study. Int J Geriatr Psychiatry. 2009 Jul;24(7):680-5. 10. Subramaniam G, Harrell P, Huntley E, Tracy
M. Beck Depression Inventory for depression screening in substance-abusing
adolescents. J Subst Abuse Treat. 2009 Jul;37(1):25-31. 11. Wachtel LE, Contrucci-Kuhn SA, Griffin M,
Thompson A, Dhossche DM, Reti IM. ECT for self-injury in an autistic
boy. Eur Child Adolesc Psychiatry. 2009 Jul;18(7):458-63. 1. Black BS, Fogarty
LA, Phillips H, Finucane T, Loreck DJ, Baker A, Blass DM, Rabins PV.
Surrogate decision makers' understanding of dementia patients' prior
wishes for end-of-life care. J Aging Health. 2009 Jun;21(4):627-50.
2. Clark MR. Psychiatric issues in chronic pain.
Curr Psychiatry Rep. 2009 Jun;11(3):243-50. 3. Everett A, Huffine C. Ethics in contemporary
community psychiatry. Psychiatr Clin North Am. 2009 Jun;32(2):329-41. 4. Ginsburg GS. The Child Anxiety Prevention Study:
intervention model and primary outcomes. J Consult Clin Psychol. 2009
Jun;77(3):580-7. 5. McGrath JA, Avramopoulos D, Lasseter VK, Wolyniec
PS, Fallin MD, Liang KY, Nestadt G, Thornquist MH, Luke JR, Chen PL,
Valle D, Pulver AE. Familiality of novel factorial dimensions of schizophrenia.
Arch Gen Psychiatry. 2009 Jun;66(6):591-600. 6. Mielke MM, Kozauer NA, Chan KC, George M, Toroney
J, Zerrate M, Bandeen-Roche 7. Moran TH. Fructose and satiety. J Nutr. 2009
Jun;139(6):1253S-1256S. 8. Peirce JM, Burke CK, Stoller KB, Neufeld KJ,
Brooner RK. Assessing traumatic event exposure: Comparing the Traumatic
Life Events Questionnaire to the Structured Clinical Interview for DSM-IV.
Psychol Assess. 2009 Jun;21(2):210-8. 9. Samus QM, Mayer L, Onyike CU, Brandt J, Baker
A, McNabney M, Rabins PV, Lyketsos CG, Rosenblatt A. Correlates of functional
dependence among recently admitted assisted living residents with and
without dementia. J Am Med Dir Assoc. 2009 Jun;10(5):323-9. 10. Vasa RA, Pine DS, Masten CL, Vythilingam M,
Collin C, Charney DS, Neumeister 1. Bienvenu OJ, Stein
MB, Samuels JF, Onyike CU, Eaton WW, Nestadt G. Personality 2. Cascella NG, Schretlen DJ, Sawa A. Schizophrenia
and epilepsy: is there a shared susceptibility?. Neurosci Res. 2009
Apr;63(4):227-35. 3. Crombag HS, Dickson M, Dinenna M, Johnson AW,
Perin MS, Holland PC, Baraban 4. Cuzzocreo JL, Yassa MA, Verduzco G, Honeycutt
NA, Scott DJ, Bassett SS. Effect of handedness on fMRI activation in
the medial temporal lobe during an auditory verbal memory task. Hum
Brain Mapp. 2009 Apr;30(4):1271-8. 5. Kidorf M, King VL, Neufeld K, Peirce J, Kolodner
K, Brooner RK. Improving substance abuse treatment enrollment in community
syringe exchangers. Addiction. 2009 May;104(5):786-95. 6. Moran TH. Gut peptides in the control of food
intake. Int J Obes (Lond). 2009 Apr;33 Suppl 1:S7-10. 7. Ratovitski T, Gucek M, Jiang H, Chighladze
E, Waldron E, D'Ambola J, Hou Z,Liang Y, Poirier MA, Hirschhorn RR,
Graham R, Hayden MR, Cole RN, Ross CA. Mutant Huntingtin N-terminal
fragments of specific size mediate aggregation and toxicity in neuronal
cells. J Biol Chem. 2009 Apr 17;284(16):10855-67. 8. Reinblatt SP, DosReis S, Walkup JT, Riddle
MA. Activation adverse events induced by the selective serotonin reuptake
inhibitor fluvoxamine in children and adolescents. J Child Adolesc Psychopharmacol.
2009 Apr;19(2):119-26. 9. Reti IM, Han S, Miskimon M, Rosen JB, Baraban
JM. Nicotine and Delta(9)-tetrahydrocannabinol withdrawal induce Narp
in the central nucleus of the amygdala. Synapse. 2009 Mar;63(3):252-5.
10. Riley AW, Coiro MJ, Broitman M, Colantuoni
E, Hurley KM, Bandeen-Roche K, Miranda J. Mental health of children
of low-income depressed mothers: influences of parenting, family environment,
and raters. Psychiatr Serv. 2009 Mar;60(3):329-36. 11. Subramaniam GA, Stitzer MA. Clinical characteristics
of treatment-seeking prescription opioid vs. heroin-using adolescents
with opioid use disorder. Drug Alcohol Depend. 2009 Apr 1;101(1-2):13-9. 12. Tamashiro KL, Terrillion CE, Hyun J, Koenig
JI, Moran TH. Prenatal stress or high-fat diet increases susceptibility
to diet-induced obesity in rat offspring. Diabetes. 2009 May;58(5):1116-25. 13. Wilcox HC, Storr CL, Breslau N. Posttraumatic
stress disorder and suicide attempts in a community sample of urban
american young adults. Arch Gen Psychiatry. 2009 Mar;66(3):305-11. 14. Willour VL, Chen H, Toolan J, Belmonte
P, Cutler DJ, Goes FS, Zandi PP, Lee RS, MacKinnon DF, Mondimore FM,
Schweizer B; Bipolar Disorder Phenome Group; NIMH Genetics Initiative
Bipolar Disorder Consortium, DePaulo JR Jr, Gershon ES, McMahon FJ,
Potash JB. Family-based association of FKBP5 in bipolar disorder. Mol
Psychiatry. 2009 Mar;14(3):261-8. 1. Anderson EL, Reti IM.
ECT in pregnancy: a review of the literature from 1941to 2007. Psychosom
Med. 2009 Feb;71(2):235-42. 2. Bahroo LB, Appleby BS. Behind the masked face:
depression and Parkinson's disease. Minerva Psichiatr 2009;50:45-53. 3. Goodwin AK, Brown PR, Jansen EE, Jakobs C,
Gibson KM, Weerts EM. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate
(GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD)
in baboons. Psychopharmacology (Berl). 2009 Feb 6. [Epub ahead of print]
4. Janofsky JS. Reducing inpatient suicide risk:
using human factors analysis to improve observation practices. J Am
Acad Psychiatry Law. 2009;37(1):15-24. 5. Peirce JM, Petry NM, Roll JM, Kolodner K, Krasnansky
J, Stabile PQ, Brown C, Stitzer ML. Correlates of stimulant treatment
outcome across treatment modalities. Am J Drug Alcohol Abuse. 2009;35(1):48-53. 6. Sedlak TW, Saleh M, Higginson DS, Paul BD,
Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant
and cytoprotective roles. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5171-6. 1. Carroll CP, Triplett PT, Mondimore FM. The
Intensive Treatment Unit: A brief inpatient detoxification facility
demonstrating good postdetoxification treatment entry. J Subst Abuse
Treat. 2009 Jan 14. [Epub ahead of print] 2. Davis LM, Michaelides M,
Cheskin LJ, Moran TH, Aja S, Watkins PA, Pei Z, Contoreggi C, McCullough
K, Hope B, Wang GJ, Volkow ND, Thanos PK. Bromocriptine administration
reduces hyperphagia and adiposity and differentially affects dopamine
D2 receptor and transporter binding in leptin-receptor-deficient Zucker
rats and rats with diet-induced obesity. Neuroendocrinology. 2009;89(2):152-62. 3. Goes FS, Willour
VL, Zandi PP, Belmonte PL, Mackinnon DF, Mondimore FM, Schweizer B,
Gershon ES, McMahon FJ, Potash JB; Bipolar Disorder Phenome Group, NIMH
Genetics Initiative Bipolar Disorder Consortium. Family-based association
study of Neuregulin 1 with psychotic bipolar disorder. Am J Med Genet
B Neuropsychiatr Genet. 2009 Jan 6. [Epub ahead of print] 4. Ladenheim EE, Behles RR, Bi S, Moran TH. Gastrin-releasing
peptide messenger ribonucleic acid expression in the hypothalamic paraventricular
nucleus is altered by melanocortin receptor stimulation and food deprivation.
Endocrinology. 2009 Feb;150(2):672-8. 5. Mahone, E M, Martin, R, Kates, WR, Hay, T,
Horska, A. Neuroimaging correlates of parent ratings of working memory
in typically developing children. Journal of the International Neuropsychological
Society 2009 Jan;15(1):31-41. 7. Sawa A, Cascella NG peripheral olfactory system
for clinical and basic psychiatry: A promising entry point to the mystery
of brain mechanism and biomarker identification in schizophrenia Am
J. Psychiatry. 2009; 166:137-139 8. Schroeder M, Shbiro L, Zagoory-Sharon O, Moran
TH, Weller A. Toward an animal model of childhood-onset obesity: follow-up
of OLETF rats during pregnancy and lactation. Am J Physiol Regul Integr
Comp Physiol. 2009 Feb;296(2):R224-32. 9. Yang L, Scott KA, Hyun J, Tamashiro KL, Tray
N, Moran TH, Bi S. Role of dorsomedial hypothalamic neuropeptide Y in
modulating food intake and energy balance. J Neurosci. 2009 Jan 7;29(1):179-90. 10. Zhang D, Cheng L, Qian Y, Alliey-Rodriguez
N, Kelsoe JR, Greenwood T, 1. Appleby BS, Appleby KK, Crain BJ, Onyike CU,
Wallin MT, Rabins PV. Characteristics of established and proposed sporadic
variants. Arch Neurol. 2009 Feb;66(2):208-15. 2. Budney, AJ., Vandrey, R.G.,
Hughes, JR., Thostenson, JD., Bursac, Z. Comparison of cannabis and tobacco
withdrawal: severity and contribution to relapse. J Subst Abuse Treat
2008 Dec;35(4):362-8. 3. Brandt J, Inscore AB, Ward J, Shpritz B, Rosenblatt
A, Margolis RL, Ross CA. Neuropsychological deficits in Huntington's disease
gene carriers and correlates of early "conversion". J Neuropsychiatry
Clin Neurosci. 2008 Fall;20(4):466-72. 4. Chen PL, Avramopoulos D, Lasseter VK, McGrath
JA, Fallin MD, Liang KY, Nestadt G, Feng N, Steel G, Cutting AS, Wolyniec
P, Pulver AE, Valle D. Fine mapping on chromosome 10q22-q23 implicates
Neuregulin 3 in schizophrenia. Am J Hum Genet. 2009 Jan;84(1):21-34. 5. Donlin WD, Knealing TW, Needham M, Wong CJ, Silverman
K. Attendance rates in a workplace predict subsequent outcome of employment-based
reinforcement of cocaine abstinence in methadone patients. J Appl Behav
Anal 2008 Winter;41(4):499-516. 6. Gherman A, Wang R, Avramopoulos D. Orientation,
distance, regulation and function of neighbouring genes. Hum Genomics.
2009 Jan;3(2):143-56. 7. Kverno KS, Rabins PV, Blass DM, Hicks K, Black
BS. Prevalence and treatment of neuropsychiatric symptoms in hospice eligible
nursing home residents with advanced dementia. Journal of Gerontological
Nursing, 2008, 34(12):8-15. 8. Lofwall, MR., Schuster, A., Strain, EC. Changing
profile of abused substances by older persons entering treatment. J Nerv
Ment Dis 2008 Dec;196(12):898-905. 9. Mahone, EM., Wodka, EL. The neurobiological profile
of girls with ADHD. Developmental Disabilities Research Reviews, 14 (4),
276-284. 10. Peirce, JM, Petry, NM, Roll, JM, Kolodner, K,
Krasnansky, J, Stabile, PQ, Brown, C, Stitzer, ML. Correlates of stimulant
treatment outcome across treatment modalities. Am J Drug Alcohol Abuse
2009 Jan;35(1):48-53. 11. Petry, NM, Roll, JM, Rounsaville, BJ, Ball,
SA, Stitzer, M., Peirce, JM, Blaine, J, Kirby, KC, McCarty, D, Carroll,
KM. Serious adverse events in randomized psychosocial treatment studies:
safety or arbitrary edicts? J Consult Clin Psychol 2008 Dec;76(6):1076-82. 12. Qui, A, Crocetti, D, Adler, M, Mahone, E., Denckla,
MB, Miller, MI, Mostofsky, S H Basal ganglia volume and shape in children
with attention deficit hyperactivity disorder. American Journal of Psychiatry,
166 (1), 74-82. 13. Silverman K, Roll JM, Higgins ST. Introduction
to the special issue on the behavior and treatment of drug addiction.
J Appl Behav Anal 2008 Winter;41(4):471-480. 14. Subramaniam, GA, Stitzer, ML, Woody, G, Fishman,
MJ, Kolodner, K. Clinical characteristics of treatment-seeking adolescents
with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend
2009 Jan;99(1-3):141-9. 15. Walsh, S.L., Chausmer, A.E., Strain, E.C., Bigelow,
G.E. Evaluation of the mu and kappa opioid actions of butorphanol in humans
through differential naltrexone blockade. Psychopharmacology 2009 Jan;196(1):143-55. 1. Kaplin A, Carroll KA, Cheng J, Allie R, Lyketsos
CG, Calabresi P, Rosenberg 2. Kinter ET, Schmeding A, Rudolph I, dosReis S,
Bridges JFP. Identifying patient-relevant endpoints among individuals
with schizophrenia: An application of patient-centered health technology
assessment. International Journal of Technology Assessment in Health Care,
2009; 25(1): 35-41. 3. Mychailyszyn MP, dosReis S, Myers MA. African-American
caretakers' views of ADHD and use of outpatient mental health care services
for children. Families, Systems and Health, 2008; 26(4): 447-458. 4. Rogers RE, Higgins ST, Silverman K, Thomas CS,
Badger GJ, Bigelow GE, Stitzer ML. Abstinence reinforcement and engagement
in non-drug-related activities among illicit drug abusers. Psychol Addict
Behav 2008 Dec;22(4):544-550. 5. Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran
C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner
JC, Munger R, Lyketsos CG. Effects of cardiovascular medications on rate
of functional decline in Alzheimer disease. Am J Geriatr Psychiatry. 2008
Nov;16(11):883-92. 6. Seow H, Piet L, Kenworthy CM, Jones S, Fagan
PJ, Morss Dy S. Evaluating a palliative care case management program for
cancer patients: the Omega Life Program. J Palliat Med. 2008 Dec;11(10):1314-8. 7. Walkup JT, Albano AM, Piacentini J, Birmaher
B, Compton SN, Sherrill JT, 8. Yang L, Scott KA, Hyun J, Tamashiro KL, Tray
N, Moran TH, Bi S. Role of dorsomedial hypothalamic neuropeptide Y in
modulating food intake and energy balance. J Neurosci. 2009 Jan 7;29(1):179-90. 1. Heil SH, Sigmon SC,
Jones HE, Wagner M. Comparison of characteristics of opioid-using pregnant
women in rural and urban settings. Am J Drug Alcohol Abuse. 2008;34(4):463-71. 2. Hutton HE, McCaul
ME, Santora PB, Erbelding EJ.The relationship between recent alcohol use
and sexual behaviors: gender differences among sexually transmitted disease
clinic patients. Alcohol Clin Exp Res. 2008 Nov;32(11):2008-15. 3. Jayaram G, Triplett P. Quality improvement of
psychiatric care: challenges of emergency psychiatry. Am J Psychiatry.
2008 Oct;165(10):1256-60. 4. Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone
maintenance vs. methadone taper during pregnancy: maternal and neonatal
outcomes. Am J Addict. 2008 Sep-Oct; 17(5):372-86. 5. Liu L, Foroud T, Xuei X, Berrettini W, Byerley
W, Coryell W, El-Mallakh R, 6. Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis
MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite
concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther.
2008 Nov;84(5):604-12. 7. Mackinnon DF, Craighead B, Lorenz L. Carbon dioxide
induces erratic respiratory responses in bipolar disorder.J Affect Disord.
2009 Jan;112(1-3):193-200. 8. Reissig CJ, Strain EC, Griffiths RR. Caffeinated
energy drinks-A growing problem. Drug Alcohol Depend. 2009 Jan 1;99(1-3):1-10. 9. Sawamura N, Ando T, Maruyama Y, Fujimuro M, Mochizuki
H, Honjo K, Shimoda M, 10. Vannorsdall TD, Jinnah HA, Gordon B, Kraut M
& Schretlen DJ. Cerebral ischemia mediates the effect of serum uric
acid on cognitive function. Stroke. 2008; 39:3418-3420. 1. Cole WR, Mostofsky SH, Gidley Larson J, Denckla
MB, & Mahone EM (2008). Age-related changes in motor subtle signs
among girls and boys with ADHD. Neurology. 2008 Nov 4;71(19):1514-20. 2. de Medeiros K, Rosenberg PB, Baker AS, Onyike
CU. Improper sexual behaviors in elders with dementia living in residential
care. Dement Geriatr Cogn Disord. 2008;26(4):370-7. 3. dosReis S, Davarya S. Staff perspectives of precipitants
to aggressive behavior of adolescents in residential treatment facilities.
Residential Treatment for Children & Youth 2008; 25:85-101. 4. Hienz RD, Brady JV, Hursh SR, Gasior ED, Spence
KR, Emurian HE. Effects of incentives on psychosocial performances in
simulated space-dwelling groups. Acta Astronautica 2008 63: 800-10. 5. Mansouri A, Aja S., Moran TH, Ronnett G, Kuhajda
FP, Arnold M, Geary N, Langhans W Leonhardt M. Intraperitoneal injections
of low doses of C75 elicit a behaviorally specific and vagal afferent-independent
inhibition of eating in rats. American Journal of Physiology. 2008 Sep;
295(3):R799-805. 6. Onyike CU. Neuroleptic discontinuation during
dementia care: a recent trial and its implications for practice. Nat Clin
Pract Neurol. 2008 Oct;4(10):528-9. 7. Smith MT, Klick B, Kozachik S, Edwards RE, Holavanahalli
R, Wiechman S, Blakeney P, Lezotte D, Fauerbach JA. Sleep onset insomnia
symptoms during hospitalization for major burn injury predict chronic
pain. Pain. 2008 Sep 15;138(3):497-506. 8. Wells CT, Mahone EM, Matson MA, Kates WR, Hay
T, Horska A. Relationship of temporal lobe volumes to neuropsychological
test performance in healthy children. Brain Cognition. 2008 Nov;68(2):171-9.
9. Woody GE, Poole SA, Subramaniam G, Dugosh K,
Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman
R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P. Extended vs short-term
buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized
trial. JAMA. 2008 Nov 5;300(17):2003-11. 1. Goldberg MC, Mostow
A, Vecera SP, Gidley-Larson JC, Mostofsky SH, Mahone EM, Denckla MB. Evidence
for impairments in using static line drawings of eye gaze cues to orient
visual-spatial attention in children with high functioning autism. Journal
of Autism and Developmental Disorders 2008 Sep;38(8):1405-13. 2. Jayaram G, Triplett
P. Quality improvement of psychiatric care: challenges for emergency psychiatry.
American Journal of Psychiatry 2008 Oct;165(10):1256-60. 3. Johnson MW, Richards
WA, Griffiths RR. Human hallucinogen research: Guidelines for Safety.
J Psychopharmacol 2008 Aug; 22(6):603-620. 4. Kamiya A, Tan PL,
Kubo K, Engelhard C, Ishizuka K, Kubo A, Tsukita S, Pulver AE, Nakajima
K, Cascella NG, Katsanis N, Sawa A. Recruitment of PCM1 to the centrosome
by the cooperative action of DISC1 and BBS4: a candidate for psychiatric
illnesses. Arch Gen Psychiatry. 2008 Sep;65(9):996-1006. 5. Kverno KS, Geiger-Brown
J, Black BS, Blass DM, Rabins PV. Neuropsychiatric symptom patterns in
hospice-eligible nursing home residents with advanced dementia. Journal
of the American Medical Directors Association 2008 Sep;9(7):509-15. 6. Magyar-Russell G,
Fosarelli P, Taylor H, Finkelstein D. Ophthalmology patients' religious
and spiritual beliefs: an opportunity to build trust in the patient-physician
relationship. Arch Ophthalmol. 2008 Sep;126(9):1262-5. 7. Mazzocco MM, Devlin
KT. Parts and 'holes': gaps in rational number sense among children with
vs. without mathematical learning disabilities. Dev Sci. 2008Sep;11(5):681-91. 8. Redgrave GW, Bakker
A, Bello NT, Caffo BS, Coughlin JW, Guarda AS, McEntee JE, Pekar JJ, Reinblatt
SP, Verduzco G, Moran TH. Differential brain activation in anorexia nervosa
to fat and thin words during a Stroop task. Neuroreport 2008 Aug 6;19(12):1181-5. 9. Reti IM, Crombag HS, Takamiya K, Sutton JM, Guo
N, Dinenna ML, Huganir RL, 10. Shi J, Wittke-Thompson JK, Badner JA, Hattori
E, Potash JB, Willour VL, McMahon 11. Wilcox HC, Grados M, Samuels J, Riddle
MA, Bienvenu OJ 3rd, Pinto A, Cullen B, 12. Wodka EL, Mostofsky SH, Prahme C, Larson
JCG, Denckla MB, Mahone EM. Process examination of executive function
in ADHD: gender and subtype effects. The Clinical Neuropsychologist 2008
Sep;22(5):826-41. 1. Cao Y-J, Smith PF, Wire MB, Lou Y, Lancaster
CT, Causon RC, Bigelow GE, Martinez E, Fuchs EJ, Radebaugh C, McCabe S,
Hendrix CW. Pharmacokinetics and pharmacodynamics of methadone enantiomers
after coadministration with fosamprenavir-ritonavir in opioid-dependent
subjects. Pharmacotherapy 2008 Jul;28(7):863-874. 4. Hienz RD, Brady JV, Gooden VL, Vazquez ME, Weed
MR. Neurobehavioral effects of head-only gamma radiation exposure in rats.
Radiation Research 2008 Sep;170(3):292-8. 5. Neufeld K, King V, Peirce J, Kolodner K, Brooner
R, Kidorf M. A comparison of 1-year substance abuse treatment outcomes
in community syringe exchange participants versus other referrals. Drug
and Alcohol Dependence 2008 Sept; 97(1): 122-129. 1. Bello NT, Kemm MH,
Moran TH. Salmon calcitonin reduces food intake through changes in meal
sizes in male rhesus monkeys. Am J Physiol Regul Integr Comp Physiol.
2008 Jul;295(1):R76-81. 2. Burdick KE, Kamiya
A, Hodgkinson CA, Lencz T, DeRosse P, Ishizuka K, Elashvili S, Arai H,
Goldman D, Sawa A, Malhotra AK. Elucidating the relationship between DISC1,
NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and
competitive binding. Hum Mol Genet. 2008 Aug 15;17(16):2462-73. 3. Paulsen JS, Langbehn
DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, McDonald
M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden
M. Detection of Huntington's disease decades before diagnosis: The Predict
HD study. J Neurol Neurosurg Psychiatry. 2008 Aug; 79(8): 874-80. 4. Perkins KA, Lerman
C, Stitzer ML, Fonte CA, Briski JL, Scott JA, Chengappa KNR. Development
of procedures for early screening of smoking cessation medications in
humans. Clin Pharmacol Ther 2008 Aug; 79 (8): 874-80. 5. Redgrave GW, Bakker
A, Bello NT, Caffo BS, Coughlin JW, Guarda AS, McEntee JE, Pekar JJ, Reinblatt
SP, Verduzco G, Moran TH. Differential brain activation in anorexia nervosa
to Fat and Thin words during a Stroop task. Neuroreport. 2008 Aug 6;19(12):1181-5. 6. Robins CS, Ware NC,
dosReis S, Willging CE, Chung JY, Lewis- Fernández R. Dialogues
on mixed-methods mental health services research: Anticipating challenges,
building Solutions. Psychiatric Services 2008 Jul;59(7):727-31. 7. Sen N, Hara MR, Kornberg
MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder
SH, Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and
mediates apoptosis. Nat Cell Biol. 2008 Jul;10(7):866-73. 8. Weed MR, Wilcox KM,
Ator NA, Hienz RD. Consistent, high-level ethanol consumption in pig-tailed
macaques via a multiple-session, limited-intake, oral self-dosing procedure.
Alcohol Clin Exp Res. 2008 Jun;32(6):942-51. 9. Zagoory-Sharon O,
Schroeder M, Levine A, Moran TH, Weller A. Adaptation to lactation in
OLETF rats lacking CCK-1 receptors: body weight, fat tissues, leptin and
oxytocin. Int J Obes (Lond). 2008 Aug;32(8):1211-21. 10. Zandi PP, Belmonte
PL, Willour VL, Goes FS, Badner JA, Simpson SG, Gershon ES, McMahon FJ,
DePaulo JR Jr, Potash JB; Bipolar Disorder Phenome Group; National Institute
of Mental Health Genetics Initiative Bipolar Disorder Consortium. Association
study of Wnt signaling pathway genes in bipolar disorder. Arch Gen Psychiatry.
2008 Jul;65(7):785-93. 1. Grados MA, Vasa RA, Riddle MA, Slomine BS, Salorio
C, Christensen J, Gerring J. New onset obsessive-compulsive symptoms in
children and adolescents with severe traumatic brain injury. Depress Anxiety
2008 May; 25(5):398-407. 2. Lyketsos CG, Szekely CA, Mielke MM, Rosenberg
PB, Zandi PP. Developing new treatments for Alzheimer's disease: the who,
what, when, and how of biomarker-guided therapies. Int Psychogeriatr.
2008 May 23:1-19. 3. MacKinnon DF. Bipolar disorder as maladaptive
arousal: a behavioral model and evidence. Annals of the NY Acad of Science
2008 May; 1129:185-189. 4. Robins CS, Ware NC, dosReis S, Willging CE, Chung
JY, Lewis Fernandez R. Dialogues on mixed-methods and mental health services
research: Anticipating challenges, building solutions. Psychiatric Services
2008 Jul; 59(7): 727-731. 5. Santora PB, Hutton HE. Longitudinal trends in
hospital admissions with co-occurring alcohol/drug diagnoses, 1994-2002.
J Subst Abuse Treat 2008 July;35:1-12. 6. Samuels JF, Bienvenu OJ, Grados MA, Cullen B,
Riddle MA, Liang KY, Eaton WW, Nestadt G. Prevalence and correlates of
hoarding behavior in a community-based sample. Behav Res Ther 2008 Jul;46(7):836-44.
7. Tarazi R, Zabel TA, Mahone EM. Age-related differences
in executive function among children with spina bifida/hydrocephalus based
on parent behavior ratings. The Clinical Neuropsychologist 2008 Jul;22(4):585-602. 8. Wilcox HC, Kellam
SG, Brown CH, Poduska JM, Ialongo NS, Wang W, Anthony JC. 9. Zandi PP, Belmonte PL, Willour VL, Goes FS, Badner
JA, Simpson SG, Gershon ES, 10. Zandi PP, Zöllner S, Avramopoulos
D, Willour VL, Chen Y, Qin ZS, Burmeister M, 1. Anderson EL, Janofsky J, Jayaram G. Argyria as
a result of somatic delusions. Am J Psychiatry 2008 May;165(5):649-50.
2. Blass DM, Black BS, Phillips H, Finucane T, Baker
A, Loreck D, Rabins PV. Medication use in nursing home residents with
advanced dementia. Int J Geriat Psych 2008 May;23(5):490-6. 3. Davydow DS, Desai SV, Needham DM, Bienvenu OJ.
Psychiatric morbidity in survivors of the acute respiratory distress syndrome:
a systematic review. Psychosom Med. 2008 May;70(4):512-9. 4. Duan W, Peng Q, Masuda N, Ford E, Tryggestad
E, Ladenheim B, Zhao M, Cadet JL, Wong J, Ross CA. Sertraline slows disease
progression and increases neurogenesis in N171-82Q mouse model of Huntington's
disease. Neurobiol Dis. 2008 Jun;30(3):312-22. 5. Eaton WW, Shao H, Nestadt G, Lee BH, Bienvenu
OJ, Zandi P. Population-based study of first onset and chronicity in major
depressive disorder. Arch Gen Psychiatry. 2008 May;65(5):513-20. 6. Goes FS, Sanders LL, Potash JB. The genetics
of psychotic bipolar disorder. Curr Psychiatry Rep. 2008 Apr;10(2):178-89.
7. Kaminski BJ, Goodwin, AK, Weerts, EM. Dissociation
of alcohol-seeking and consumption under a chained schedule of oral alcohol
reinforcement in baboons. Alcohol Clin Exp Res. 2008 Jun;32(6):1014-1022.
8. Maust DT, Blass DM, Black BS, Rabins PV. Treatment
decisions regarding hospitalization and surgery for nursing home residents
with advance dementia: The CareAD Study. International Psychogeriatrics,
2008, 20(2):406-418. 9. Masuda N, Peng Q, Li Q, Jiang M, Liang Y, Wang
X, Zhao M, Wang W, Ross CA, Duan W. Tiagabine is neuroprotective in the
N171-82Q and R6/2 mouse models of Huntington's disease. Neurobiol Dis.
2008 Jun;30(3):293-302. 10. Pinto A, Greenberg BD, Grados MA, Bienvenu OJ
3rd, Samuels JF, Murphy DL, Hasler G, Stout RL, Rauch SL, Shugart YY,
Pauls DL, Knowles JA, Fyer AJ, McCracken JT, Piacentini J, Wang Y, Willour
VL, Cullen B, Liang KY, Hoehn-Saric R, Riddle MA, Rasmussen SA, Nestadt
G. Further development of YBOCS dimensions in the OCD Collaborative Genetics
Study: Symptoms vs. categories. Psychiatry Res. 2008 Jul15: 160(1):83-93.
11. Schretlen DJ, Testa SM, Winicki JM, Pearlson
GD, Gordon B. Frequency and bases of abnormal performance by healthy adults
on neuropsychological testing. J Int Neuropsychol Soc. May 2008;14(3):436-445.
12. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis
RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker
PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C,
Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee
KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson
M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH,
Gurling HM, Purcell SM. Collaborators: Marangell LB, Calabrese JR, Nierenberg
AA, Hauser P, Ketter TA, Thomas M, Patel J, Fossey MD, Gyulai L, Thase
ME, Bowden CL, Molay F, Rosen-Sheidley B, Silfies L, Gejman PV, Sanders
AR, Amin F, Buccola N, Byerley W, Cloninger CR, Crowe R, Black D, Freedman
R, Levinson D, Mowry B, Silverman J, Nurnberger J, Miller MJ, Bowman ES,
Rau NL, Moe PR, Samavedy N, El-Mallakh R, Manji H, Glitz DA, Meyer ET,
Smiley C, Foroud T, Flury L, Dick DM, Edenberg H, Rice J, Reich T, Goate
A, Bierut L, McInnis M, DePaulo JR Jr, MacKinnon DF, Mondimore FM, Potash
JB, Zandi PP, Avramopoulos D, Payne J, Berrettini W, Byerley W, Vawter
M, Coryell W, Crowe R, Gershon E, Badner J, McMahon F, Liu C, Sanders
A, Caserta M, Dinwiddie S, Nguyen T, Harakal D, Kelsoe J, McKinney R,
Scheftner W, Kravitz HM, Marta D, Vaughn-Brown A, Bederow L, McMahon FJ,
Kassem L, Detera-Wadleigh S, Austin L, Murphy DL. Whole-genome association
study of bipolar disorder. Mol Psychiatry. 2008 Jun;13(6):558-69. 13.Terracciano A, Löckenhoff CE, Crum RM, Bienvenu
OJ, Costa PT Jr. Five-factor model personality profiles of drug users.
BMC Psychiatry. 2008 Apr 11;8:22. 14. Verma R, Holmans P, Knowles JA, Grover D, Evgrafov
OV, Crowe RR, Scheftner WA, Weissman MM, Depaulo JR Jr, Potash JB, Levinson
DF. Linkage Disequilibrium Mapping of a chromosome 15q25-26 major depression
linkage region and sequencing of NTRK3. Biol Psychiatry. 2008 Jun 15;63(12):1185-9.
15. Yassa MA, Verduzco G, Cristinzio C, Bassett
SS. Altered fMRI activation during mental rotation in those at genetic
risk for Alzheimer's disease. Neurology. 2008 May 13; 70:1898-1904. 1. Blass DM, Black BS, Philips H, Finucane T, Baker
A, Loreck D, Rabins PV. Medication use in nursing home residents with
advanced dementia. International Journal of Geriatric Psychiatry. 2008
May;23(5):490-6. 2. dosReis S, Myers MA. Parental attitudes and involvement
in psychopharmacological treatment for ADHD: a conceptual model. Int Rev
Psychiatry. 2008 Apr;20(2):135-41. 3. dosReis S, Johnson E, Steinwachs D, Rohde C,
Skinner AE, Fahey M, Lehman AF. Antipsychotic treatment patterns and hospitalizations
among adults with schizophrenia. Schizophr Res. 2008 Apr;101(1-3):304-11.
4. Lanier RK, Umbricht A, Harrison JA, Nuwayser
ES, Bigelow GE. Opioid detoxification via single 7-day application of
a buprenorphine transdermal patch: An open-label evaluation. Psychopharmacology
2008 Apr;101(1-3):304-11. 5. Meda SA, Giuliani NR, Calhoun VD, Kanchana J,
Schretlen DJ, Pulver A, Cascella N, Keshavan M, Kates W, Buchanan R, Sharma
T & Pearlson GD. A large scale (N=400) investigation of gray matter
differences in schizophrenia using optimized voxel-based morphometry.
Schizophr Res. Apr 2008;101(1-3):95-105. 6. Payne JL, MacKinnon DF, Mondimore FM, McInnis
MG, Schweizer B, Zamoiski RB,McMahon FJ, Nurnberger JI Jr, Rice JP, Scheftner
W, Coryell W, Berrettini WH, Kelsoe JR, Byerley W, Gershon ES, DePaulo
JR Jr, Potash JB. Familial aggregation of postpartum mood symptoms in
bipolar disorder pedigrees. Bipolar Disord. 2008 Feb;10(1):38-44. 7. Roeder MB, Mahone EM, Gidley Larson J, Mostofsky
SH, Cutting LE, Goldberg MC, Denckla MB. Left-right differences on timed
motor examination in children. Child Neuropsychol. 2008 May;14(3):249-62. 8. Rudnicki, D.D., Pletnikova, O., Vonsattel, J.P.,
Ross, C.A., Margolis, R.L. A Comparison of Huntington Disease and Huntington
Disease-Like 2 Neuropathology. (2008) J Neuropathol Exp Neurol. 67, 366-374. 9. Wachtel LE, Kahng S, Dhossche DM, Cascella N,
Reti IM. ECT for catatonia in an autistic girl. Am J Psychiatry. 2008
Mar;165(3):329-33. 10. Wodka EL, Loftis C, Mostofsky SH, Prahme C,
Larson JC, Denckla MB, Mahone EM. Prediction of ADHD in boys and girls
using the D-KEFS. Arch Clin Neuropsychol. 2008 May;23(3):283-93. 1. dosReis S, Myers MA. Parental attitudes and involvement
in psychopharmacological treatment for ADHD: A conceptual model. International
Review of Psychiatry. 2008 April; 20(2):135-141 2. Harris, K.M, Mahone, E. M., Singer, H.S. Nonautistic
motor stereotypies: clinical features and longitudinal follow-up. Pediatr
Neurol 2008 April; 38(4):267-272. 3. Knealing, TW, Roebuck, MC, Wong, CJ, Silverman,
K. Economic cost of the therapeutic workplace intervention added to methadone
maintenance. J Subst Abuse Treat. 2008 Apr; 34(3):326-32. 4. Liu Z, Wang X, Yu Y, Li X, Wang T, Jiang H, Ren
Q, Jiao Y, Sawa A, Moran T, Ross CA, Montell C, Smith WW. A Drosophila
model for LRRK2-linked parkinsonism. Proc Natl Acad Sci U S A. 2008 Feb
19;105(7):2693-8. 5. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross
CA, Duan W. The antidepressant sertraline improves the phenotype, promotes
neurogenesis and increases BDNF levels in the R6/2 Huntington's disease
mouse model. Exp Neurol. 2008 Mar;210(1):154-63. 6. Payne JL, MacKinnon DF, Mondimore FM, McInnis
MG, Schweizer B, Zamoiski RB, McMahon FJ, Nurnberger JI Jr, Rice JP, Scheftner
W, Coryell W, Berrettini WH, Kelsoe JR, Byerley W, Gershon ES, DePaulo
JR Jr, Potash JB.Familial aggregation of postpartum mood symptoms in bipolar
disorder pedigrees. Bipolar Disorders. 2008 Feb;10(1):38-44. 7. Pletnikov MV, Ayhan Y, Xu Y, Nikolskaia O, Ovanesov
M, Huang H, Mori S, Moran TH, Ross CA. Enlargement of the lateral ventricles
in mutant DISC1 transgenic mice. Mol Psychiatry. 2008 Feb;13(2):115. 8. Stitzer ML, Vandrey R. Contingency management:
Utility in the treatment of drug abuse disorders. Clin Pharmacol Ther
2008 Apr;83(4):644-647. 10. Stitzer ML. Brief interventions for tobacco
cessation. Addiction 2008 Feb;103(2):305-306. 1. Chen J, Scott KA,
Zhao Z, Moran TH, Bi S. Characterization of the feeding inhibition and
neural activation produced by dorsomedial hypothalamic cholecystokinin
administration. Neuroscience. 2008 March; (152) 178-188. 2. McKibben JB, Bresnick
MG, Wiechman Askay SA, Fauerbach JA. Acute stress disorder and posttraumatic
stress disorder: a prospective study of prevalence, course, and predictors
in a sample with major burn injuries. J Burn Care Res. 2008 Jan-Feb; 29(1):22-35. 3. Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein
RC. Effect of depression on late (8 years) mortality after myocardial
infarction. Am J Cardiol. 2008 Mar 1; 101(5):602-6. 4. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross
CA, Duan W. The antidepressant sertraline improves the phenotype, promotes
neurogenesis and increases BDNF levels in the R6/2 Huntington's disease
mouse model. Exp Neurol. 2008 Mar; 210(1):154-63. 5. Thombs BD, Notes LD, Lawrence JW, Magyar-Russell
G, Bresnick MG, Fauerbach JA. From survival to socialization: a longitudinal
study of body image in survivors of severe burn injury. J Psychosom Res.
2008 Feb; 64(2):205-12. 1. Aja S, Landree LE, Kleman AM, Medghalchi SM,
Vadlamudi A, McFadden JM, Aplasca A, Hyun J, Plummer E, Daniels K, Kemm
M, Townsend CA, Thupari JN, Kuhajda FP, Moran TH, Ronnett GV. Pharmacological
stimulation of brain carnitine palmitoyl-transferase-1 decreases food
intake and body weight. Am J Physiol Regul Integr Comp Physiol. 2008 Feb;
294(2):R352-61. 2. Goes FS, Sadler B, Toolan J, Zamoiski RD, Mondimore
FM, Mackinnon DF, Schweizer B; Bipolar Disorder Phenome Group, Raymond
Depaulo J Jr, Potash JB. Psychotic features in bipolar and unipolar depression.
Bipolar Disord. 2007 Dec;9 (8):901-6. 3. Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder
JR, Jasinski DR, Johnson RE, Jones HE, Huestis MA. Buprenorphine and norbuprenorphine
in hair of pregnant women and their infants after controlled buprenorphine
administration. Clinical Chemistry 2007 Dec; 53 (12): 2136-2143. 4. Nestadt G, Costa PT Jr, Hsu FC, Samuels J, Bienvenu
OJ, Eaton WW. The relationship between the five-factor model and latent
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
personality disorder dimensions. Compr Psychiatry. 2008 Jan-Feb; 49(1):98-105.
5. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov
MV, Huang H, Mori S, Moran TH, Ross CA. Inducible expression of mutant
human DISC1 in mice is associated with brain and behavioral abnormalities
reminiscent of schizophrenia. Mol Psychiatry. 2008 Feb;13(2):173-86. 7. Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS,
Frost JJ, McCaul M E. Differences in delta- and mu-opioid receptor blockade
measured by PET in naltrexone-treated recently abstinent alcohol-dependent
subjects. Neuropsychopharmacology 2008 Feb; 33(3): 653-665. 8. Yasumoto F, Hayashi A, Kamiya A, Negishi T, Yoshikawa
Y, Sawa A. Genetic manipulation of brain cultures from the primates: a
novel tool for molecular studies of neuropsychiatric disorders. Mol Psychiatry.
2008 Feb;13(2):116-118. 1. Black BS, Brandt J,
Rabins PV, Samus QM, Steele CD, Lyketsos CG, Rosenblatt A. Predictors
of providing informed consent or assent for research participation in
assisted living residents. American Journal of Geriatric Psychiatry, 2008
January;16(1):83-91. 2. Easterbrook JD, Kaplan JB, Glass GE, Pletnikov
MV, Klein SL. Elevated testosterone and reduced 5-HIAA concentrations
are associated with wounding and hantavirus infection in male Norway rats.
Horm Behav. 2007 Nov;52(4):474-81. 3. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey
R, Brasic J, Ye W, Alexander 4. McKibben J, Bresnick MG, Askay Wiechman SA, Fauerbach
JA. Acute stress disorder and posttraumatic stress disorder: A prospective
study of prevalence, course and predictors with major sample major burn
injuries. J. Burn Care Research. 2008 January/February;29(1):22-35. 5. Potash JB, Buervenich S, Cox NJ, Zandi PP, Akula
N, Steele J, Rathe JA, Avramopolous D, Detera-Wadleigh SD, Gershon ES,
Depaulo JR Jr, Feinberg AP, McMahon FJ, NIMH Genetics Initiaive Bipolar
Disorder Consortium. Gene-based SNP mapping of a psychotic bipolar affective
disorder linkage region on 22q12.3: Association with HMG2L1 and TOM1.
Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147(1):59-67 6. Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney
MC. QT-interval effects of methadone, levomethadyl, and buprenorphine
in a randomized trial. Arch Intern Med. 2007 Dec 10;167(22):2469-75. 7. Winstanley EL, Steinwachs DM, Ensminger
ME, Latkin CA, Stitzer ML, Olsen Y. 1. Carroll CP, Kidorf
M, Strain EC, Brooner RK. Comparison of demographic and clinical characteristics
between opioid-dependent individuals admitted to a community-based treatment
setting and those enrolled in a research-based treatment setting. J Subst
Abuse Treat. 2007 Dec;33(4):355-361. 2. de Lateur BJ, Magyar-Russell G, Bresnick MG,
Bernier FA, Ober MS, Krabak BJ, Ware L, Hayes MP, Fauerbach JA. Augmented
exercise in the treatment of deconditioning from major burn injury. Arch
Phys Med Rehabil. 2007 Dec;88(12 Suppl 2):S18-23. 3. Edwards RR, Magyar-Russell G, Thombs B, Smith
MT, Holavanahalli RK, Patterson DR, Blakeney P, Lezotte DC, Haythornthwaite
JA, Fauerbach JA. Acute pain at discharge from hospitalization is a prospective
predictor of long-term suicidal ideation after burn injury. Arch Phys
Med Rehabil. 2007 Dec;88(12 Suppl 2):S36-42. 4. Esselman PC, Askay SW, Carrougher GJ, Lezotte
DC, Holavanahalli RK, Magyar-Russell G, Fauerbach JA, Engrav LH. Barriers
to return to work after burn injuries. Arch Phys Med Rehabil. 2007 Dec;88(12
Suppl 2):S50-6. 5. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken
RH, Webster MJ, Dinkins T,Callinan PA, Fan JB, Potash JB, Feinberg AP.
DNA methylation signatures within the human brain. Am J Hum Genet. 2007
Dec;81(6):1304-15. 6. Lezotte DC, Hills RA, Heltshe SL, Holavanahalli
RK, Fauerbach JA, Blakeney P, Klein MB, Engrav LH. Assets and liabilities
of the Burn Model System data model: a comparison with the National Burn
Registry. Arch Phys Med Rehabil. 2007 Dec;88(12 Suppl 2):S7-17. 7. Lofwall MR, Walsh SL, Bigelow GE, Strain EC.
Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
Psychopharmacology 2007 Oct;194(3):381-93. 8. McCann UD, Ricaurte GA. Effects of (+/-) 3,4
-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms.
ScientificWorldJournal 2007 Nov;7:231-8. 9. Schroeder M, Lavi-Avnon Y, Zagoory-Sharon O,
Weller A, Moran TH. Preobesity in the infant OLETF rat: The role of suckling.
Dev Psychobiol. 2007 Nov;49(7):685-91. 10. Stitzer ML, Petry N, Peirce J, Kirby K, Killeen
T, Roll J, Hamilton J, Stabile PO, Sterling R, Brown C, Kolodner K, Li
R. Effectiveness of abstinence-based incentives: Interaction with intake
stimulant test results. J Consult Clin Psychol 2007 Oct;75(5):805-11. 11. Verma R, Cutler DJ, HolmansP, Knowles JA, Crowe
RR, Scheftner WA, Weissman MM, DePaulo JR Jr, Levinson Df, Potash JB.
Investigating the role of p11 (S100A10) sequence variation in susceptibility
to major depression. Am J Med Genet B Neuropsychiatr Genet. 2007 May 17 1. Bienvenu OJ, Hettema JM, Neale MC, Prescott CA,
Kendler KS. Low extraversion and high neuroticism as indices of genetic
and environmental risk for social phobia, agoraphobia,
and animal phobia. Am J Psychiatry. 2007 Nov;164(11):1714-21. 2. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly
S, Strynadka K, Chohnan S, Smith WW, Tamashiro KL, Ladenheim EE, Ronnett
GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH. Leptin activates hypothalamic
acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci U S
A. 2007 Oct 30;104(44):17358-63. 3. Hamshere ML, Holmans PA, Avramopoulous D, Bassett
SS, Blacker D, Bertram L, 4. Lanier RK, Umbricht A, Harrison JA, Nuwayser
ES, Bigelow GE. Evaluation of a transdermal buprenorphine formulation
in opioid detoxification. Addiction 2007 Oct;102(10):1648-56. 5. Pucak ML, Carroll KA, Kaplin AI, Kerr DA Neuropsychiatric
manifestations of depression in multiple sclerosis: neuroinflammatory,
neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated
depression. Dialogues in Clinical Neuroscience, 2007; 9(2): 125-39. 6. Rosado J, Walsh SL, Bigelow GE, Strain EC. Sublingual
buprenorphine/naloxone precipitated withdrawal in subjects maintained
on 100mg of daily methadone. Drug Alcohol Depend 2007 Oct;90(2-3):261-9. 7. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut
M, Pearlson GD, Gordon B, Jinnah HA. Serum uric acid and brain ischemia
in normal elderly adults. Neurology. 2007 Oct 2;69(14):1418-1423. 8. Silverman K, Wong CJ, Needham M, Diemer KN, Knealing
T, Crone-Todd D, Fingerhood M, Nuzzo P, Kolodner K A randomized trial
of employment-based reinforcement of cocaine abstinence in injection drug
users. J Appl Behav Anal. 2007;40:387-410. 1. Nwulia EA, Miao K, Zandi PP, Mackinnon DF, DePaulo
JR Jr, McInnis MG. Genome-wide scan of bipolar II disorder. Bipolar Disord
2007 Sep;9(6):580-8. 2. Payne JL. Antidepressant use in the postpartum
period: practical considerations. Am J Psychiatry. 2007 Sep;164(9):1329-32. 3. Potash JB, Toolan J, Steele J, Miller EB, Pearl
J, Sandi PP, Schultze TG, Kassem L, Simpson SG, Lopez V, NIMH Genetics
Initiative Bipolar Disorder Consortium, MacKinnon DF, McMahon FJ. The
bipolar disorder phenome database: a resource for genetic studies. Am
J Psychiatry. 2007 Aug;164(8):1229-37. 1. Black BS, Kass NE, Fogarty LA, Rabins PV. Informed
consent for dementia research: The study enrollment encounter. IRB: Ethics
& Human Research 2007, 29(4):7-14. 2. Cascella NG, Takaki M, Lin S, Sawa A. Neurodevelopmental
involvement in schizophrenia: the olfactory epithelium as an alternative
model for research. J Neurochem 2007 Aug;102(3):587-94. 3. Colomer Gould VF, Goti D, Pearce D, Gonzalez
G, Gao H, Bermudez de Leon M, Jenkins NA, Copeland N, Ross CA, and Brown
DR. A mutant ataxin-3 fragment results from processing at a site N-terminal
to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
Neurobiology of Disease 2007; 27: 362-9. 4. Fagan PJ. Sex therapy and research: a view from
health services research. Journal of Sex and Marital Therapy. 2007: 33:5,
427 -432. 5. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K,
Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher
M, Ishizuka K, Pletnikov M, Kida S, Sawa A. From the Cover: Dominant-negative
DISC1 transgenic mice display schizophrenia-associated phenotypes detected
by measures translatable to humans. Proc Natl Acad Sci U S A 2007 Sep;104(36):14501-6. 6. Matsuzawa D, Hashimoto K, Miyatake R, Shirayama
Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, Ozaki N,
Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Hata A, Sawa
A, Iyo M. Identification of functional polymorphisms in the promoter region
of the human PICK1 Gene and their association with methamphetamine psychosis.
Am J Psychiatry 2007 Jul;164(7):1105-14. 7. Potash JB, Toolan J, Steele J, Miller EB, Pearl
J, Zandi PP, Schulze TG, Kassem L, Simpson SG, Lopez V. NIMH Genetics
Initiative Bipolar Disorder Consortium, MacKinnon DF, McMahon FJ. The
bipolar disorder phenome database: a resource for genetic studies. Am
J Psychiatry. 2007 Aug;164(8):1229-37. 8. Schretlen DJ, Cascella NG, Meyer SM, Kingery
LR, Testa SM, Munro CA, Pulver AE, 9. Scott KA, Moran TH. The GLP-1 agonist exendin-4
reduces food intake in nonhuman primates through changes in meal size.
Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R983-987. 10. Sindelar JL, Olmstead TA, Peirce JM. Cost-effectiveness
of prize-based contingency management in methadone maintenance treatment
programs. Addiction 2007 Sept; 102 (9): 1463-1471. 11. Stitzer ML, Peirce J, Petry N, Kirby K, Roll
J, Krasnansky J, Cohen A, Blaine J, Vandrey R, Kolodner K, Li R. Abstinence-based
incentives in methadone maintenance: Interaction with intake stimulant
test results. Experimental and Clinical Psychopharmacology; 2007 Aug;15(4):344-50. 12. Subramaniam, GA, Stitzer MA, Clemmey P, Kolodner,
K, Fishman, MJ. Baseline depressive symptoms predict poor substance use
outcome following adolescent residential treatment. 13. Weerts EM, Fantegrossi WE, Goodwin AK. The value
of nonhuman primates in drug abuse research. Exp Clin Psychopharmacol.
2007 Aug;15(4):309-27. 14. Weerts EM, Froestl W, Kaminski BJ, Griffiths
RR. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen
and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons.
Drug Alcohol Depend. 2007 Jul 10;89(2-3):206-13. Epub 2007 Jan 16. 1. Grover D, Woodfield
AS, Verma R, Zandi PP, Levinson DF, Potash JB. Quick SNP: an automated
web server for selection of tagSNPs. Nucleic Acids Res.2007 July 1:35
(Web Server issue)W115-20 2. Kalaydijan A, Eaton W, Zandi P. Migraine headaches
are not associated with a unique depressive symptom profile: Results from
the Baltimore Epidemiologic Catchment Area Study. J Psychosomatic Res
2007 Aug 63(2):123-9. 3. Lofwall MR, Walsh SL, Bigelow GE, Strain EC,
Experimentally-induced spontaneous opiate withdrawal: relationship to
cigarette craving and expired air carbon monoxide. Am J Addict. 2007 Jul-Aug;16(4):310-5. 4. Mondimore FM, Zandi PP, MackinnonDF, McInnis
MG, Miller EB. Schweizer B, Crowe RP, Scheftner WA, Weissman MN, Levinson
DF, DePaulo JR Jr, Potash JB. A comparison of the famiality of chronic
depression in recurrent early onset depression pedigrees using different
definitions of chronicity. J Affective Disorders 2007 June: 100(1-3):171-7.
5. Pletnikov MV, Xu Y, Ovanesov MV, Kamiya A, Sawa
A, Ross CA. PC12 cell model of inducible expression of mutant DISC1: New
evidence for a dominant-negative mechanism of abnormal neuronal differentiation.
Neurosci Res. 2007 Jul;58(3):234-44. 6. Swartz KL, KastelicEA, Hess SG, Cox TS,
Gonzales LC, Mink SP, DePaulo JR Jr. The effectiveness of a school-based
adolescent depression education program. Health Education Behavior 2007
July 25 [Epub ahead of print]. 1. Bi S, Chen J, Behles RR, Hyun J, Kopin AS, Moran
TH. D ifferential body weight and feeding responses
to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. 2. Fauerbach JA, McKibben J, Bienvenu OJ, Magyar-Russell
G, Smith MT, Holavanahalli 3. Matsuzawa D, Hashimoto K, Miyatake R, Shirayama
Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, Ozaki N,
Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Hata A, Sawa
A, Iyo M. Identification of functional polymorphisms in the promoter region
of the human PICK1 gene and their association with methamphetamine psychosis.
Am J Psychiatry 2007 Jul;164(7):1105-14 4. Ovanesov MV, Vogel MW, Moran TH, Pletnikov MV
Neonatal Borna disease virus infection in rats is associated with increased
extracellular levels of glutamate and neurodegeneration in the striatum.
J Neurovirol. 2007 Jun;13(3):185-94. 5. Zandi PP, Avramopoulos D, Willour VL, Huo Y,
Miao K, Mackinnon DF, McInnis MG, Potash JB, Depaulo JR. SNP fine mapping
of chromosome 8q24 in bipolar disorder. Am J Med Genet B Neuropsychiatr
Genet. 2007 Mar 13 6. Zandi PP, Badner JA, Steele J, Willour VL, Miao
K, Mackinnon DF, Mondimore FM, Schweizer B, McInnis MG, Depaulo Jr JR,
Gershon E, McMahon FJ, Potash JB. Genome-wide linkaghe scam of 98 bipolar
pedigress and analysis of clinical covariates. Mol Psychiatry. 2007 May
15 1. Brooner RK, Kidorf
MS, King VL, Stoller KB, Neufeld KJ, Kolodner K. Comparing adaptive stepped
care and monetary-based voucher interventions for opioid dependence. Drug
Alcohol Depend. 2007 May;88 Suppl 2:S14-23. 2. Chan D, Kasper JD, Black BS, Rabins PV. Clinical
diagnosis of dementia, not presence of behavioral and psychological symptoms,
is associated with psychotropic use in community-dwelling elders classified
as having dementia. Journal of Geriatric Psychiatry and Neurology 2007
Jun;20(2):100-6. 3. Jayaram G. Implementing performance improvement
and measuring psychiatric care quality. Psychiatry 2007 May; 4:58-61. 4. Kidorf M, Neufeld K, King VL, Clark M, Brooner
RK. A stepped care approach for reducing cannabis use in opioid-dependent
outpatients. J Subst Abuse Treat. 2007 Jun;32(4):341-7. 5. Mondimore FM, Zandi PP, Mackinnon DF, McInnis
MG, Miller EB, Schweizer B, Crowe RP, Scheftner WA, Weissman MM, Levinson
DF, Depaulo JR Jr, Potash JB. A comparison of the familiality of chronic
depression in recurrent early-onset depression pedigrees using different
definitions of chronicity. J Affect Disord. 2007 June, 100 (1-3): 171-7.
6. Olaniyan O, dosReis S, Garriett V, Mychailyszyn
MP, Anixt J, Rowe PC, Cheng TL. Community perspectives of childhood behavioral
problems and ADHD among African American parents. Ambulatory Pediatrics
2007 May-June; 7(3): 226-231. 7. Rabins PV, Black BS. Measuring quality of life
in dementia: Purposes, goals, challenges and progress. International Psychogeriatrics,
2007; June 19(3):401-407. 8. Rao V, Spiro JR, Schretlen DJ, Cascella NG. Apathy
syndrome after traumatic brain injury compared with deficits in schizophrenia.
Psychosomatics. 2007 May-Jun;48(3):217-22. 9. Rao V, Handel S, Vaishnavi S, Keach S, Robbins
B, Spiro J, Ward J, Berlin F. Psychiatric sequelae of traumatic brain
injury: a case report . Am J Psychiatry 2007 May; 164: 728-735. 10. Weerts EM, Froestl W, Kaminski BJ, Griffiths
RR. Attenuation of cocaine-seeking by GABA(B) receptor agonists baclofen
and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons.
Drug Alcohol Depend. 2007 Jul 10;89(2-3):206-13. 1. Avramopoulos D, Wang
R, Valle D, Fallin MD, Bassett SS. A novel gene derived from a segmental
duplication shows perturbed expression in Alzheimer's disease. Neurogenetics.
2007 Apr;8(2):111-20. 2. Balciuniene J, Feng N, Iyadurai K, Hirsch B,
Charnas L, Bill BR, Easterday MC, Staaf J, Oseth L, Czapansky-Beilman
D, Avramopoulos D, Thomas GH, Borg A, Valle D, Schimmenti LA, Selleck
SB. Recurrent 10q22-q23 Deletions: A genomic disorder on 10q associated
with cognitive and behavioral abnormalities. Am J Hum Genet. 2007 May;80(5):938-47. 3. Cheslack-Postava K, Fallin MD, Avramopoulos D,
Connors SL, Zimmerman AW, Eberhart CG, Newschaffer CJ. beta2-Adrenergic
receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatry.
2007 Mar;12(3):283-91. 4. DosReis S, Mychailyszyn MP, Myers M, Riley AW.
Coming to terms with ADHD: how urban african-american families come to
seek care for their children. Psychiatr Serv. 2007 May;58(5):636-41. 5. Grados MA, Samuels J, Shugart YY, Willour VL,
Wang Y, Cullen B, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle
MA, Wendland JR, Murphy DL, Nestadt G, Detera-Wadleigh S. Rare plus common
SERT variants in obsessive-compulsive disorder. Mol Psychiatry. 2007 May;12(5):422-3.
6. Kinzig, K.P., Coughlin, J.W., Redgrave, G.W.,
Moran T.H. and Guarda, A.S.: Insulin, glucose and pancreatic polypeptide
responses to a test meal in restricting type anorexia nervosa before and
after weight restoration. American Journal of Physiology, 292: E1441-1445. 7. Lyketsos CG. Neuropsychiatric symptoms (behavioral
and psychological symptoms of dementia) and the development of dementia
treatments. Int Psychogeriatr. 2007 Mar 9;1-12 8. Olson LE, Roper RJ, Sengstaken CL, Peterson EA,
Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH. Trisomy
of Down syndrome "critical region" is necessary but not sufficient
for brain phenotypes of trisomic mice. Human Molecular Genetics, 16:774-782,
2007. 9. Schroeder M, Lavi-Avnon Y, Dagan M, Zagoory-Sharon
O, Weller A, Moran TH. Diurnal and nocturnal nursing behavior in the OLETF
rat. Developmental Psychobiology 2007, 43: 323-333. 10. Thombs BD, Magyar-Russell G, Bass, Stewart KJ,
Tsilidis KK, Bush DE, Fauerbach JA, McCann UD, Ziegelstein RC. Performance
characteristics of depression screening instruments in survivors of acute
myocardial infarction: review of the evidence. Psychosomatics. 2007 May-Jun;48(3):185-94. 1. Hayden KM, Welsh-Bohmer
KA, Wengreen HJ, Zandi PP, Lyketsos CG, Breitner JC; 2. Hienz RD, Brady JV, Hursh SR, Banner MJ, Gasior
ED, Spence, KR. Communication constraints, indexical countermeasures,
and crew configuration effects in simulated space dwelling groups. Acta
Astronautica, 2007, 60:362-378. (Feb-March Issue) 3. Podewils LJ, Guallar E, Beauchamp N, Lyketsos
CG, Kuller LH, Scheltens P. Physical activity and white matter lesion
progression: assessment using MRI. Neurology 2007 Apr 10;68(15):1223-6.
4. Rudnicki DD, Holmes SE, Lin M, Thorton CA, Ross
CA, Margolis RL. Huntington's disease-like 2 is associated with CUG repeat
containing RNA foci. Ann Neurol 2007: 61:272-82. 5. Samuels J, Shugart YY, Grados MA, Willour VL,
Bienvenu OJ, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy
DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Rasmussen
SA, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. Significant
linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive
disorder: results from the OCD Collaborative Genetics Study. 6. Smith MT, Edwards RR., McCann U, Haythornthwaite
JA. The effects of sleep deprivation on pain inhibition and spontaneous
pain in women. Sleep, 2007;30(4):494-505. 7. Thombs BD, Bresnick MG, Magyar-Russell G, Lawrence
JW, McCann UD, Fauerbach JA. 8. Schroeder M, Lavi-Avnon Y, Dagan M, Zagoory-Sharon
O, Weller A, Moran TH. Diurnal and nocturnal nursing behavior in the OLETF
rat. Dev Psychobiol. 2007 Apr;49(3):323-33. 1. Bi S. Role of dorsomedial hypothalamic
neuropeptide Y in energy homeostasis. Peptides. 2007 Feb;28(2):352-6 2. Blass DM. A pragmatic approach to teaching psychiatric
residents the assessment and treatment of religious patients. Academic
Psychiatry 2007; 31(1):25-31. 3. Goes FS, Zandi PP, Miao K, McMahon FJ, Steele
J, Willour VL, MacKinnon DF, Mondimore FM, Schweizer B, Bipolar Disorder
Phenome Group, Nurnberger Jr JI; Rice JP, Scheftner W, Coryell W, Berrettini
WH, Kelsoe JR, Byerley W, Murphy DL, Gershon ES, DePaulo Jr JR, McInnis
MG, and Potash JB. Mood-incongruent psychotic features in bipolar disorder:
familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33.
Am J Psychiatry 2007; 164: 236-247. 5. Klein MB, Lezotte DL, Fauerbach JA, Herndon DN,
Kowalske KJ, Carrougher GJ, deLateur BJ, Holavanahalli R, Esselamn PC,
SanAgustin TB, Engrav LH. The NIDRR Burn Model System database: A tool
for the multi-center study of outcome of burn injury. J Burn Care Rehabil.
2007 January/February;28(1):84-96. 6. Kaufman MS, Graham CC, Lezotte D, Fauerbach JA,
Gabriel V, Engrav LH, Esselman P. Burns as a result of assault: associated
risk factors, injury characteristics and outcomes. J Burn Care Rehabil.
2007 January/February;28(1):21-28. Key words: burn injury, assault, burn
model system, longitudinal outcomes 7. Leroi I, Samus QM, Rosenblatt A, Onyike CU, Brandt
J, Baker AS, Rabins P, Lyketsos C. A comparison of small and large assisted
living facilities for the diagnosis and care of dementia: the Maryland
Assisted Living Study. Int J Geriatr Psychiatry 2007 Mar:22(3):224-32. 8. Levinson DF, Evgrafov OV, Knowles JA, Potash
JB, Weissman MM, Scheftner, WA, Depaulo JR Jr, Crowe RR, Murphy-Eberenz
K, Marta DH, McInnis MG, Adams P, Gladis M, Millerr EB, Thomas J, Holmans
P. Genetics of recurrent early-onset depression (GenRED): significant
linkage on chromosome 15q25-q26 after fine mapping with single nucleotide
polymorphism markers. Am J Psychiatry 2007; 164: 259-264. 9. MacKinnon DF, Craighead B, Hoehn-Saric R: Carbon
dioxide provocation of anxiety and respiratory response in bipolar disorder.
J Affect Disord 2007 Apr;99(1-3):45-9. 10. Payne JL, Roy PS, Murphy-Eberenz K, Weissman
MM, Swartz KL, McInnis MG, Nwulia E, Mondimore FM, MacKinnon DF, Miller
EB, Nurnberger JI, Levinson DF, DePaulo JR, and Potash JB. Reproductive
cycle-associated mood symptoms in women with major depression and bipolar
disorder. J Affect Disord 2007; 99: 221-229. 11. Perry RT, Wiener H, Harrell LE, Blacker D, Tanzi
RE, Bertram L, Bassett SS, Go RC. Follow-up mapping supports the evidence
for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease
Genetics Initiative cohort. Am J Med Genet B Neuropsychiatr Genet. 2007
Mar 5;144(2):220-7. 12. Samuels J, Shygart YY, Grados MA, Willour VL,
Bienvenu OJ, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy
DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Rasmussen
SA, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. Significant
linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive
disorder: results from the OCD collaborative genetics study. Am J Psychiatry
2007; 164: 493-499. 13. Thombs BD, Haines JM, Bresnick MG, Magyar-Russell
G, Fauerbach JA, Spence RJ. Depression in burn reconstruction patients:
symptom prevalence and association with body image dissatisfaction and
physical function. Gen Hosp Psychiatry. 2007 Jan-Feb; 29(1):14-20. 14. Willour VL, Zandi PP, Badner JA, Steele
J, Miao K, Lopez V, MacKinnon DF, Mondimore FM, Schweizer B, McInnis MG,
the Bipolar Disorder Phenome Group, DePaulo JR, Gershon ES, McMahon FJ,
and Potash JB. Attempted suicide in bipolar disorder pedigrees: evidence
for linkage to 2p12. Biol Psychiatry 2007; 61(5):725-727. 1. Donny E, Houtsmuller E, Stitzer ML. Smoking in
the absence of nicotine: behavioral, subjective and physiological effects
over 11 days. Addiction 2007 Feb;102:324-334. 2. Goes FS, Zandi PP, Miao K, McMahon FJ, Steele
J, Willour VL, Mackinnon DF, Mondimore FM, Schweizer B, Nurnberger JI
Jr, Rice JP, Scheftner W, Coryell W, Berrettini WH, Kelsoe JR, Byerley
W, Murphy DL, Gershon ES, Bipolar Disorder Phenome Group, Depaulo JR Jr,
McInnis MG, Potash JB. Mood-incongruent psychotic features in bipolar
disorder: familial aggregation and suggestive linkage to 2p11-q14 and
13q21-33. Am J Psychiatry. 2007 Feb;164(2):236-47. 3. Guarda AS, Marinilli Pinto A, Couglin J, Hussain
S, Haug NA, Heinberg LJ. Perceived coercion and change in perceived need
for admission in hospitalized eating disorder patients. Am J Psychiatry
2007; Jan;164:108-114. 5. Redgrave, G.W., Coughlin J.W., Heinberg, L. J.
& Guarda, A.S. First-degree relative history of alcoholism in eating
disorder inpatients: relationship to eating and substance use psychopathology.
Eating Behaviors 2007 Jan;8(1):15-22. 6. Schretlen DJ, Inscore AB, Jinnah HA, Rao V, Gordon
B, Pearlson GD. Serum uric acid and cognitive function in community-dwelling
older adults. Neuropsychology. 2007 Jan;21(1):136-140. 7. Thombs BD, Haines J, Bresnick MG, Magyar-Russell
G, Fauerbach JA, Spence RJ. Depression in burn reconstruction patients:
Symptom prevalence and association with body image dissatisfaction and
physical function. Gen Hosp Psychiatry, 2007 Jan-Feb;29(1):14-20. 8. Weerts EM, Goodwin AK, Kaminski BJ, Hienz
RD. Environmental cues, alcohol seeking, and consumption in baboons: effects
of response requirement and duration of alcohol abstinence. 1. Black BS, Finucane
T, Baker A, Loreck D, Blass D, Fogarty L, Phillips H, Hovanec L, Steele
C, Rabins PV. Health problems and correlates of pain in nursing home residents
with advanced dementia. Alzheimer Disease and Associated Disorders, 2006,
20(4):283-290. 2. Bracha HS, Bienvenu OJ, Eaton WW. Testing the
Paleolithic-human-warfare hypothesis of blood-injection phobia in the
Baltimore ECA Follow-up Study-Towards a more etiologically-based conceptualization
for DSM-V. J Affect Disord 2007 Jan; 97(1-3):1-4. 3. Correia CJ, Walsh SL, Bigelow GE, Strain EC.
Effects associated with double-blind omission of buprenorphine/naloxone
over a 98-h period. Psychopharmacology 2006 Dec;189(3):297-306. 4. Janofsky, JS. Lies and coercion: Why psychiatrists
should not participate in police and intelligence interrogations. J Am
Acad Psychiatry Law 2006; 34:472-478 5. Jayaram G. The physician advisor's role in contemporary
psychiatry and quality of care. Psychiatry 2006; 3:50-56. 6. Juliano LM, Houtsmuller EJ, Stitzer ML. A preliminary
investigation of rapid smoking as a lapse-responsive treatment for tobacco
dependence. Experimental and Clinical Psychopharmacology 2006 Nov;14:429-38. 7. Kaminsky M, McCabe L, Langlieb AM, Everly GS.
An evidence-informed model of human resistance, resilience, and recovery:
The Johns Hopkins' outcomes-driven paradigm for disaster mental health
services. Brf Tr and Cris Interv. 2006 Dec 7: 1-11. 8. Kingery LR, Schretlen DJ, Sateri S, Langley LK,
Marano NC, Meyer SM. Interrater and test-retest reliability of a fixed
condition design fluency test. The Clinical Neuropsychologist. Dec 2006;20(4):729-740. 9. MacKinnon DF, Zamoiski R: Panic comorbidity with
bipolar disorder: what is the manic-panic connection? Bipolar.Disord 2006;
8:648-664 10. Mintzer MZ, Kuwabara H, Alexander M, Brasic
JR, Ye W, Ernst M, Griffiths RR, Wong DF. Dose effects of triazolam on
brain activity during episodic memory encoding: a PET study. Psychopharmacology
2006;188:445-61. 11. Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce
JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, Kellogg S.
Contingency management for the treatment of methamphetamine use disorders.
American Journal of Psychiatry 2006 Nov;163:1993-9. 12. Weerts EM, Goodwin AK, Kaminski BJ, Hienz RD.
Environmental cues, alcohol seeking, and consumption in baboons: effects
of response requirement and duration of alcohol abstinence. Alcohol Clin
Exp Res. 2006 Dec; 30(12):2026-36. 13. Wong DF, Kuwabara H, Schretlen DJ, et
al. Increased occupancy of dopamine receptors in human striatum during
cue-elicited cocaine craving. Neuropsychopharmacology. Dec 1. Blackshaw S, Eliasson
MJL, Sawa A, Watkins CC, Krug D, Gupta A, Arai T, Ferrante RJ, Snyder
SH. Hippocampal neuronal and endothelial nitric oxide synthase: species,
strain, developmental and spatial variations relevant to nitric oxide-dependent
synaptic plasticity. Neuroscience 2003; 119; 979-990 2. Djousse L, Knowlton B, Hayden M, Almqvist EW,
Brinkman R, Ross CA, Margolis RL, Rosenblatt A, Durr A, Dode C , Morrison
PJ, Novelletto A, Frontali M, Trent RJA, McCusker E, Gomez-Tortosa E,
Mayo D, Jones R, Zanko A, Nance M, Abramson R, Suchowersky O, Paulsen
J, Harrison M, Yang Q, Cupples LA, Gusella JF, MacDonald ME, Myers RH.
Interaction of Normal and Expanded CAG Repeat, Sizes Influences Age at
Onset of Huntington Disease, American Journal of Medical Genetics 2003;119A:279-82. 3. Holmes SE, O’Hearn E, Margolis RL. Why is
SCA12 different from other SCAs? Cytogenetic and Genome Research 2003;
100:189-97. 4. Kerenyi L, Ricaurte GA, Schretlen DJ, McCann
U, Varga J, Mathews WB, Ravert HT, Dannals RF, Hilton J, Wong DF, Szabo
Z. Positron emission tomography of striatal serotonin transporters in
Parkinson disease. Arch Neurol 2003; 60; 1223-1229. 5. MacKinnon DF, Zandi PP, Gershon E, Nurnberger
JI, Jr., Reich T, DePaulo JR. Rapid switching of mood in families with
multiple cases of bipolar disorder. Arch Gen Psychiatry 2003; 60(9):921-928. 6. MacKinnon DF, Zandi PP, Gershon ES, Nurnberger
JI, Jr., DePaulo JR, Jr. Association of rapid mood switching with panic
disorder and familial panic risk in familial bipolar disorder. Am J Psychiatry
2003; 160(9):1696-1698. 7. Margolis RL, Ross CA. Diagnosis of Huntington
Disease. Clin Chem. 2003 Oct;49(10):1726-1732. 8. Reti IM, Baraban JM. Opiate withdrawal induces
Narp in the extended amygdala. Neuropsychopharmacology. 2003 Sep;28(9):1606-13. 9. Rosenblatt A, Abbott MH, Gourley LM, Troncoso
JC, Margolis RL, Brandt J, Ross CA. Predictors of neuropathological severity
in 100 patients with Huntington's disease. Ann Neurol. 2003 Oct;54(4):488-93. 10. Rudnicki D, Margolis RL. Repeat expansion and
the autosomal dominant neurodegenerative disorders: consensus and controversy,
Expert Reviews in Molecular Medicine 2003; 5 11. Sawa A, Kamiya A. Elucidating the pathogenesis
of schizophrenia. Brit. Med. J 2003; 327: 632-633 12. Sawa A, Tomoda T, Bae BI. Mechanisms for neuronal
cell death in Huntington's disease. Cytogenet Genome Res 2003; 100:287-295 13. Schretlen DJ, Munro CA, Anthony JC, Pearlson
GD. Examining the range of normal intra-individual variability in neuropsychological
test performance. J Intl Neuropsychol Soc 2003; 9; 864-870. 14. Walker RH, Rasmussen A, Rudnicki D, Holmes SE,
Alonso E, Matsuura T, Ashizawa T, Davidhoff-Feldman B, Margolis RL. Huntington
Disease-like 2 can present as autosomal dominant chorea-acanthocytosis.
Neurology 2003; 61:1002-1004. Key words: neuropeptide Y; leptin; corticotropin-releasing factor; mRNA expression http://www.sciencedirect.com/science?_ob=MImg&_imagekey =B6T0P-491J537-9-F&_cdi=4868&_orig=browse&_coverDate =09%2F30%2F2003&_sk=999209995&view=c&wchp= dGLbVzz-zSkWW&_acct=C000006078&_version=1&_userid =75682&md5=f84f5e2731b181078c3cb9344c3a3f44 1. Balster RL, Bigelow
GE. Guidelines and methodological reviews concerning drug abuse liability
assessment. Drug and Alcohol Dependence 2003; 70 (3 Suppl), S13-40. 2. Bi S, Robinson BM, Moran TH. Acute food deprivation
and chronic food restriction differentially affect hypothalamic NPY mRNA
expression. Am J Physiol Regul Integr Comp Physiol 2003; Jul 3 [Epub ahead
of print] 3. Li JL, Hayden MR, Almqvist EW, Brinkman RR, Durr
A, Dode C, Morrison PJ, Suchowersky O, Ross CA, Margolis RL, Rosenblatt
A, Gomez-Tortosa E, Cabrero DM, Novelletto A, Frontali M, Nance M, A Trent
RJ, McCusker E, Jones R, Paulsen JS, Harrison M, Zanko A, Abramson RK,
Russ AL, Knowlton B, Djousse L, Mysore JS, Tariot S, Gusella MF, Wheeler
VC, Atwood LD, Cupples LA, Saint-Hilaire M, Cha JH, Hersch SM, Koroshetz
WJ, Gusella JF, MacDonald ME, Myers RH. A genome scan for modifiers of
age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet
2003; Aug 1 [Epub ahead of print]. 4. Pletnikov MV, Rubin SA, Moran TH, Carbone KM.
Exploring the cerebellum with a new tool: neonatal Borna disease virus
(BDV) infection of the rat's brain. Cerebellum 2003; 2(1):62-70. 1. Ator NA, Griffiths
RR. Principles of drug abuse liability assessment in laboratory animals.
Drug and Alcohol Dependence 2003; 70(3, Supplement):S55-S72. 2. Chen H, Wang N, Huo Y, Sklar P, MacKinnon DF,
Potash JB, McMahon FJ, Antonarakis SE, DePaulo JR, Ross CA, McInnis MG.
Trapping and sequence analysis of 1138 putative exons from human chromosome
18. Mol Psychiatry 2003;8(6):619-623. 3. Griffiths RR, Bigelow GE, Ator NA. Principles
of initial experimental drug abuse liability assessment in humans. Drug
and Alcohol Dependence 2003; 70, S41-S54. 4. Griffiths RR, Juliano LM, Chausmer AL. Caffeine
pharmacology and clinical effects. Graham AW, Schultz TK, Mayo-Smith MF,
Ries RK., Wilford BB. (eds.) In: Principles of Addiction Medicine Third
Edition, 2003; pp. 193-224. Chevy Chase, MD: American Society of Addiction.
5. Kaminski BJ, Sannerud CA, Weerts EM, Lamb RJ,
Griffiths RR. Physical dependence in baboons chronically treated with
low and high doses of diazepam. Behavioural Pharmacology 2003; 14:331-342. 6. Strain EC, Griffiths RR. Substance Abuse: Caffeine
Use Disorders. In: A. Tasman, J. Kay, J.A. Lieberman (Eds.) Psychiatry,
2003; pp. 973-994. London: John Wiley & Sons, Ltd. 7. Walsh SL, Eissenberg T. Buprenorphine: Extrapolating
from clinical pharmacology to clinical practice. Drug and Alcohol Dependence
2003;70: S13-27. 8. Weerts EM, Griffiths RR. The adenosine receptor
antagonist CGS15943 reinstates cocaine-seeking behavior and maintains
self-administration in baboons. Psychopharmacology 2003; 168, 155-163. 1. Hensler JG, Ladenheim
EE, Lyons WE. Ethanol consumption and serotonin-1A (5-HT1A) receptor function
in heterozygous BDNF (+/-) mice. J Neurochem 2003; 85(5):1139-1147. 2. Nestadt G, Addington A, Samuels J, Liang KY,
Bienvenu OJ, Riddle M, Grados M, Hoehn-Saric R, Cullen B. Identification
of OCD-related subgroups based on co-morbidity. Biol Psychiatry 2003;
53:914-920. 3. Nucifora FC Jr, Ellerby LM, Wellington CL, Wood
JD, Herring WJ, Sawa A, Hayden MR, Dawson VL, Dawson TM, Ross CA. Nuclear
localization of a non-caspase truncation product of atrophin-1, with an
expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem
2003; 278(15):13047-55. 4. Silverman K, Higgins ST, Bickel WK. The therapeutic
workplace: Applied behavior analysis in the treatment of drug addiction.
In: K. S. Budd and T. Stokes (Eds.), A Small Matter of Proof: The Legacy
of Donald M. Baer, 2003; pp. 195-210. Reno, NV: Context Press. 5. Walsh SL, Eissenberg T. The clinical pharmacology
of buprenorphine: extrapolating from the laboratory to the clinic. Drug
Alcohol Depend 2003; 70(2 Suppl):S13-27. 1. Mohan D, Neufeld K,
Chopra A, Sethi H. Agreement between head of household informant and self-report
in a community survey of substance use in India. Drug Alcohol Depend 2003;
69(1):87-94. 2. Moran TH. Pancreatic polypeptide: More than just
another gut hormone? Gastroenterology 2003;124(5):1542-4. 3. Potash JB, Zandi PP, Willour VL, Lan TH, Avramopoulos
D, Huo Y, Shugart YY, MacKinnon DF, Simpson SG, McMahon FJ, DePaulo Jr
JR, McInnis MG. Suggestive linkage to chromosomal regions 13q31 and 22q12
in families with psychotic bipolar disorder. Am J Psychiatry 2003;160(4):680-6. 4. Smedh U, Moran TH. Peptides that regulate food
intake: Separable mechanisms for dorsal hindbrain CART peptide to inhibit
gastric emptying and food intake. Am J Physiol Regul Integr Comp Physiol
2003;284(6):R1418-R1426. 1. Bienvenu OJ. There was
no sex difference in genetic correlations between neuroticism and major
depression (invited commentary). Evidence-Based Mental Health 2003; 6(1):16.
2. Codori AM, Zawacki KL, Peteresen GM, Miglioretti
DL, Bacon JA, Brensinger JD, Booker SV, Picarello K, Giardiello FM. Genetic
testing for hereditary colorectal cancer in children: Long term psychological
effects. Am J Med Genet 2003; 116A:117-128. 3. Gallucci G, Buccino D, Cournoyer M. Challenges
related to thioridazine use in patients with mental retardation and developmental
disabilities. Mental Health Aspects of Developmental Disabilities 2003;
6(1):1-5. 4. Hienz RD, Weed MR, Zarcone T J, Brady JV. Cocaine’s
effects on detection, discrimination, and identification of auditory stimuli
by baboons. Pharmacol Biochem Behav 2003; 74:287-296. 5. Igarashi S, Morita H, Bennett KM, Tanaka Y, Engelender
S, Peters MF, Cooper JK, Wood JD, Sawa A, Ross CA. Inducible PC12 cell
model of Huntington's disease shows toxicity and decreased histone acetylation.
Neuroreport 2003;14(4):565-8. 6. Kuo I, Brady J, Butler C, Schwartz
R, Brooner R, Vlahov D, Strathdee S. Feasibility of referring drug users
from a needle exchange program into an addiction treatment program: Experience
with a mobile treatment van and LAAM maintenance. J Subst Abuse Treat
2003; 24:67-74. 7. Mintzer MZ, Griffiths RR. Lorazepam and scopolamine:
A single-dose comparison of effects on human memory and attentional processes.
Exp Clin Psychopharmacol. 2003; 11:56-72. 8. Walsh SL, Strain EC, Bigelow GE. Evaluation of
the effects of lofexidine and clonidine on naloxone-precipitated withdrawal
in opioid-dependent humans. Addiction 2003; 98: 427-439. 9. Zacny J, Bigelow G, Compton P, Foley K, Iguchi
M, Sannerud C. College on problems of drug dependence taskforce on prescription
opioid non-medical use and abuse: position statement. Drug Alcohol Depend.,
2003; 69:215-232. 1. Blacker D, Bertram L, Saunders AJ, Moscarillo
TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney
A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis
MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE. Results of a high-resolution
genome screen of 437 Alzheimer's Disease families. Hum Mol Genet. 2003
Jan 1;12(1):23-32 2. Dallery J, Houtsmuller EJ, Pickworth WB, Stitzer
ML. Effects of cigarette nicotine content and smoking pace on subsequent
craving and smoking. Psychopharmacology (Berl). 2003 Jan;165(2):172-80 3. Donny, E.C., Walsh, S.L., Bigelow, G.E.. Choosing
to take cocaine in the human laboratory: The effects of cocaine dose,
inter-choice-interval, and the magnitude of alternative reinforcement.
Drug Alcohol Depend. 2003 Apr 1;69(3):289-301 4. Haythornthwaite JA, Wegener S, Benrud-Larson
L, Fisher B, Clark M, Dillingham T, Cheng L, DeLateur B. Factors associated
with willingness to try different pain treatments for pain after a spinal
cord injury. Clin J Pain. 2003 Jan-Feb;19(1):31-8 5. Jiang H, Nucifora FC Jr, Ross CA, DeFranco DB.
Cell death triggered by polyglutamine-expanded huntingtin in a neuronal
cell line is associated with degradation of CREB-binding protein. Hum
Mol Genet. 2003 Jan 1;12(1):1-12 6. Lawrence JW, Fauerbach JA. Personality, coping,
chronic stress, social support and PTSD symptoms: A path analysis. Journal
of Burn Care & Rehabilitation. 2003; 24: 63-72 7. Leroi I, Voulgari A, Breitner JC, Lyketsos CG.
The epidemiology of psychosis in dementia. Am J Geriatr Psychiatry. 2003
Jan-Feb;11(1):83-91 8. McCabe OL, Gwon HS, McHugh PR, Breakey WR, Schwartz
JM, Clark MR, Kaminsky MJ. l Academic Psychiatry and Health Care Reform:
Strategic initiatives for sustaining the clinical mission. Psychiatric
Services. 2003; 54(2): 236-239 9. Mintzer MZ, Griffiths RR. Lorazepam and scopolamine:
A single-dose comparison of effects on human memory and attentional processes.
Exp Clin Psychopharmacol. 2003 Feb;11(1):56-72 10. Ozeki, Y., T. Tomoda, J. Kleiderlein, A. Kamiya,
L. Bord, K. Fujii, M. Okawa, N. Yamada, M. E Hatten, S.H. Snyder, C. A.
Ross, A. Sawa Disrupted-In-Schizophrenia-1 (DISC-1): mutant truncation
prevents binding to NUDEL and inhibits neurite outgrowth. Proc. Natl.
Acad. Sci. USA. 2003; 100; 289-294 11. Potash JB, Chiu YF, MacKinnon DF, Miller EB,
Simpson SG, McMahon FJ, McInnis MG, and DePaulo Jr JR. Familial aggregation
of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees.
Am J Med Genet. 2003;116B:90-7 12. Toole LM, Bowman LG, Thomason JL, Hagopian LP,
Rush, KS. Observed increases in positive affect during behavioral treatment.
Behavioral Interventions. 2003; 18, 35-42. 13. Walkup JT, Labellarte MJ, Riddle MA, Pine D,
Greenhill L, Klein R, Davies M, Sweeney M, Fu C, Abikoff H, Hack S, Klee
B, McCracken J, Bergman L, Piacentini J, March J, Compton S, Robinson
J, O'Hara T, Baker S, Vitiello B, Ritz L, Roper M. Searching for moderators
and mediators of pharmacological treatment effects in children and adolescents
with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2003 Jan;42(1):13-21.
14. Wong CJ, Sheppard JM, Dallery J, Bedient G,
Robles E, Svikis D, Silverman K. Effects of reinforcer magnitude on data
entry productivity in chronically unemployed drug abusers participating
in a Therapeutic Workplace. Experimental and Clinical Psychopharmacology.
2003; 11, 46-55
Return to top of Publications - Psychiatry Archives
|
 |
|
||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM |
|
|
